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Abstract 
Since the publication of the human and mouse genomes, several efforts have been 
undertaken to elucidate not only their coding gene content, but also the full catalogue of 
other functional non-coding elements contained within them. During my PhD I 
contributed to the characterization of a novel set of 8,000 genes, prevalently non-coding, 
and a novel set of 20,000 enhancer elements. 
In order to identify novel genes within the mouse genome we used the gene 
trapping approach in ES cells. Embryonic stem (ES) cells are pluripotent cells with the 
capacity of self-renewal and the ability to differentiate into specific cell lineages. In this 
work was performed the first genome-wide analysis of the mouse ES cell transcriptome 
using 250,000 gene trap sequence tags deposited in all available public databases. We 
identified >8,000 novel transcripts of which a great part revealed as non-coding, and 
>1,000 novel alternative and often tissues specific exons of known genes. We validate 
experimentally 70% of the expression of these genes and exons by RT-PCR. We isolated, 
within the set studied, a novel non-coding transcript that showed a highly specific pattern 
of expression by in situ hybridization in mouse embryos. Our analysis also shows that the 
genome presents gene trapping hotsposts, which correnspond to 383 known and 87 novel 
genes. These “hypertrapped” genes show minimal overlap with previously published 
expression profiles of ES cells; however, we demonstrate by real time PCR that 
“hypertrapped” genes are highly expressed in this cell type, letting us hypothesize that 
these genes could potentially contribute to the phenotype of ES cells. Thus the further 
studies of these genes, could help enlucidate the “stemness” transcriptional profile. 
Although gene trapping was initially used as an insertional mutagenesis technique, our 
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study demonstrates its impact on the discovery of a substantial and unprecedented portion 
of the transcriptome. 
In the second part of this work we focused our attention on conserved non-coding 
elements acting as enhancers. Generally speaking, non-coding regions are less conserved 
with respect to the protein-coding regions and their underlying syntax is not as clear. 
Conservation in non-coding sequence across the vertebrate subphylum has been shown to 
be a good predictor of regions which are involved in the regulation of the expression. 
Thus one way of predicting whether a DNA sequence is functionally important is the 
comparative analysis of orthologous non-coding regions across genomes belonging to 
this subphylum. In particular, in this work, using a global-local alignment on orthologous 
loci which takes into account the positional shuffling of regulatory regions across long 
evolutionary distances we identified over 20,000 vertebrate conserved elements, an order 
of magnitude more than previously reported. We demonstrated that 72% of these 
elements identified have indeed undergone to shuffling during the 450 million years 
separating fish from mammalian organisms. Furthermore we validated their function in 
vivo by testing their capability to act as enhancers when injected in zebrafish embryos 
and we demonstrated that more than 80% of these identified elements identified indeed 
act as enhancers often in a tissue specific manner. 
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INTRODUCTION 
Genomic features 
The eukaryotic genome contains several levels of complexity as demonstrated by re-
association kinetics of its denatured DNA. In fact, DNA re-association occurs in three 
distinct phases, and each of them represents a different component (Fig. 1). Highly 
repetitive DNA represents 25% of the genome, DNA that is moderately repetitive 
represents a further 30% and 45% of the genome hosts non-repetitive DNA. The latter is 
known to contain coding genes as well as many other functional elements. 
Functional elements of the genome can be classified further into coding and non-coding 
genes, pseudogenes, enhancers repressors and insulators, microRNA and many elements 
which probably still escape a complete understanding. Only a small portion of the 
genome, about the 2-3% of the mammalian genome, encodes mRNAs that encode for 
proteins, and the protein-coding sequence is located within large introns or intergenic 
regions (see Fig. 2).  
The traditional genetic definition of a gene as a segment of DNA that is able to 
complement a mutant phenotype has become more complex in recent years, because it 
has become clear that the genomic sequence alone cannot be used to infer function, 
without taking into account a further complexity derived from alternative splicing. The 
set of transcripts that is derived from the genome composes the transcriptome. While in 
lower eukaryotic organisms the traditional paradigm of one gene, one transcript, one 
protein is likely to be valid for the majority of genes, in mammals it has become evident 
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in recent years that the transcriptome introduces a further, significant, layer of 
complexity.  
The Fantom consortium (Carnici et al., 2005) has shown clearly that individual 
genomic loci can produce a moltitude of overlapping transcripts. These transcripts, 
identified as full-length cDNAs, can be shown computationally to form clusters of 
overlapping sequences. A cluster of transcripts can arise from an expressed pseudogene, 
and an individual locus can encode clusters from both strands. This effort has shown 
clearly that the transcriptome is organized on the genome in complex regions, defined as 
transcriptional forests, which present a high complexity of sense and anti-sense, coding 
and non-coding transcripts.  
Importantly, it has been shown that this variability is due to the fact that approximately 
63% of the genome is transcribed at least from one strand (in comparison to previous 
findings that only the 2% of the genome is transcribed in protein coding mRNA), and that 
transcriptional units contains several alternative splice variants (Fig. 3), also due to the 
fact that many transcripts have multiple transcription start sites as well polyadenylation 
sites. Thus, overall, this project has clearly shown that the transcriptome is much larger 
and more complex than previously thought. 
Coding sequences: exons 
Protein-coding regions result from several coding sequences that are interrupted by 
stretches of non-coding sequences that are spliced out during mRNA maturation. Exons 
are defined as DNA sequences found in mature mRNA while introns are segments of 
DNA that are cut out in the final mRNA. Interestingly, some introns contain important 
information (such as splice enhancers and splice silencers, as well as enhancers) and 
                                                                                                                                                                                         INTRODUCTION  
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sometimes can even code for other completely different genes, the so called “nested 
genes” (see Fig. 4). 
The non-coding world 
For much over 50 years, the functional portion of the genome was considered to 
be the one that codes for proteins and, until recently, most evolutionary studies of DNA 
sequences have focused completely on this translated fraction. There are many theories 
on the origins of non-coding DNA which suggest that the bulk of these sequences is 
DNA debris with no meaning (Lynch et al., 2003) and invoke random accumulation of 
this “junk”, such as the action of selfish self-replicating elements (Orgel et al., 1980).  
The idea that a wide proportion of the eukaryotic genomes contain elements 
conserved across evolution stems from the problem known as the “c-value paradox” 
where “c” stands for the total amount of DNA in the haploid genome. In fact, genome 
size does not correlate with organism complexity: for example, the unicellular organism 
Amoeba dubia containes approximately 200 times as much DNA as humans, while 
humans have about 7.5 times as much as the pufferfish Fugu rubiprens, although this 
organism has a comparable number of genes (Brenner et al., 1993). Most of the variation 
in genome size is due to the non-coding sequences, often very simple, repeated 
sequences. 
The mammalian genome contains the instructions for many undiscovered non-
protein coding RNA genes. About 0.5% of the human genome is represented by 
pseudogenes, but a large portion consists of introns and intergenic DNA. In fact, about 
half of the intergenic DNA consist of several type of transposons, while the remaninig 
non coding portion contains other elements responsible for the expression of genes, 
                                                                                                                                                                                         INTRODUCTION  
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structural elements responsible for chromosome function as well as remnants of 
evolution, all elements which constitute the non coding world or the so called “dark 
matter” of the genome (Hayashikizaki et al., 2006). 
Despite recent elucidation of the extent of the genome which is transcribed, there are still 
large regions termed “gene deserts” which occupy a significant part of the genome. These 
are long regions which contain no transcribed sequences and without obvious biological 
function (Venter et al., 2001). Some studies have shown that gene deserts can contain 
regulatory sequences that act at a large distance to control the expression of neighboring 
genes (Nobrega et al., 2003; Kimura-Yoshida et al., 2004). These include cis-regulatory 
sequences that control gene expression (enhancers, insulators other boundary elements, 
and sequences that anchor genomic region to specific nuclear regions)(Dorsett et al., 
1999; Bell et al., 2001; Carter et al., 2002) that can usually function in an orientation and 
often even position independent manner (Blakwood et al., 1998) influencing the 
activation or the specificity of a nearby promoter. In contrast, it has been demonstrated 
that some gene deserts do not seem to be essential to genome function since their deletion 
in mouse does not seem to cause a phenotype (Russel et al., 1982; Nobrega et al., 2004). 
Thus, further studies will be required to elucidate the role, if any, of these regions.  
Repetitive sequences and mobile DNA sequences 
The human genome contains also stretches of repeated non-coding elements of 
various length and copy of number (identical and/or similar copies). Repetitive sequences 
make up at least 50% of the entire human genome. They are classified by function and 
dispersal pattern. These repetitive sequences are called “tandem repeats” if present as a 
sequence motifs lying adjacent to each other in the same block, or “interspersed repeats” 
if the repetitive sequences are scattered along the genome as single units flanked by 
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unique sequence. Although their relevance as functional elements is still unclear, even if 
we assumed that repeated elements do not play an important functional role, a large 
amount of non-coding non-repetitive DNA remains to be elucidated. 
Tandem repeats and Micro mini macro satellite repeats  
Tandem repeats contain successive identical repeat units. This class of elements 
includes satellite DNA, minisatellite and microsatellite repeats; satellite sequences are 
quite variable in repeat size and in array size. Microsatellites are the smallest, at a repeat 
size of 4 bp or less. Moreover, recently macrosatellites have been discovered which are 
moderately repetitive and contain tandem repeats of a larger size in some cases ORFs can 
be as long as 4-10kb long (Gondo et al., 1998). 
Whether these sequences often as short sequences as 2-3 bps and repeated as often as 
thousands of times, play a functional role is still unclear. Often these sequences appear to 
function collectively rather than individually, and their dispensability is not an indicator 
of non-functionality. It is noteworthy that in the genome of Fugu rubripes, a highly 
compact vertebrate genome most repeat families found in other vertebrates are present, 
although in very limited copy number, sometimes as small as a single copy (Aparicio et 
al., 2002). Satellite DNA sequences are abundant in constitutive heterocromatine. In 
particular they are involved preponderantly in the organization of the centromeres, the 
sites in which every chromosome attach to cellular tethers and are pulled during mitosis. 
Moreover, minisatellites are enriched in subtelomeric regions of the chromosome. 
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Interspersed repeats: Transposable elements 
Retroelements 
One of the most common classes of repeats (~35% of the genome) is that of 
dispersed retroelements (Jurka et al., 1998). Retrotasposones can be classified into two 
categories: autonomous and non-autonomous (Fig. 5). While the former encode for a 
protein necessary for trasposition, the latter do not encode a protein. For this reason the 
latter need a separate protein product encoded by another trasposon to perform their 
trasposition. Another classification of these transposable elements is based on the mode 
of trasposition (Finegan et al., 1989). The “class I mobile elements” is capable to 
reproduce itself using an RNA intermediate which is reversed transcribed to DNA by a 
reverse transcriptase enzyme encoded on intact elements (Fig. 6). It has been observed 
that these elements require an RNA polymerase (II or III) to be transcribed into RNA and 
thereafter be transposed, while the original DNA copy is preserved in the same location. 
Short and long interspersed elements, named SINEs and LINEs respectively, represent 
the majority of this class of repeats and they form a group called non-LTR elements. The 
remaining part of this class comprises LTR trasposons, structurally similar to integrated 
retroviruses, and retrogenes. Finally the elements belonging to class II move by a 
conservative “cut and paste mechanism”, which involves the excision of the donor 
element is followed by its insertions elsewhere in the genome (Fig. 6). 
LTR retrotrasposons 
LTR retrotrasposons are remnants of endogenous retroviruses which represent 8% 
of the genome and are usually 7-9kb long. They contain, like the proviruses, long 
terminal repeats (LTR), gag, pol, and prt genes with the difference that one of the 
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proteins responsible for the infection, the env protein, is mutated or missing. Thus, these 
elements can only move within cells. The human genome contains only “evolutionary 
fossils” of these elements which are highly mutated and are not capable of transposition 
any longer.  
LINEs 
LINEs (long interspersed nuclear elements) are autonomous retrotrasposons. 
These sequences represent 21% of the human genome. In particular the most abundant in 
humans are Alu and the LINE-1 sequences (Lander et al., 2001). LINE-1 sequences alone 
comprises the 17% of the genome. The basic active element, about 6 kb long, called L1 
contains two open reading frames, ORF1 and ORF2, a 5’UTR, which acts also as a 
promoter and a 3’UTR containing a polyadenylation signal. It is known that ORF2 is 
responsible for integration in the genome and that it contains an endonuclease domain as 
well as a reverse transcriptase domain. The function of the product of ORF1 is still 
unclear, it is only known that it binds to L1 mRNA. After the L1 mRNA transcription, it 
is transported in the cytoplasm, thus ORF1 is translated. The translation, then, is restarted 
to an internal ribosome entry site to translate ORF2. This process in eukaryotes occurs 
rarely so that only a little portion of L1 has its ORF2. Both proteins binds L1 and this 
complex is traslocated into the nucleus. The ORF2 acts by cutting the DNA at the target 
site. This process is not particularly specific, but occurs preferentially for AT rich 
sequences. This cut occurs unequally and generates sticky ends; thus the free 3’OH group 
is used by the reverse transcriptase encoded by ORF2 for the synthesis of the first cDNA 
strand. The mechanism of synthesis of the second cDNA strand is still unknown, but it is 
known that the end result is a stable integration of a double stranded L1 DNA in a new 
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location within the genome. Thus LINEs can be considered vectors for DNA shuffling 
thus contributing to DNA relocation events of small fragments (such as exons and 
enhancers) within the genome. The L1 element is flanked by target sites for duplication 
which span 7-20 bps. Owing to the fact that the reverse trascriptase does not always 
finish transcription of the first strand, the newly formed copy is often truncated at the 5’ 
end. Moreover, the lacking of the proofreading activity in the process leads to the 
introduction of several mutations within the new copy. 
SINEs 
SINEs (short interspersed nuclear elements) do not encode for any protein and 
tipically their length is shorter than 500bp. Among them the Alu elements (which derive 
their name derived form the identification of AluI restriction sites) represent about 11% 
of the human genome. These elements share a consensus of about 282bp that derives 
presumably from the SRP (signal recognition particle) RNA subunit (7SL RNA). Alus 
are transcribed by the RNA Pol III, the same enzyme which transcribes the 7SL RNA 
gene. Morever, Alus are capable to bind two SRP proteins (SRP9 and SRP14). It has 
been suggested, therefore, that Alus can bind to the ribosome machinery and that through 
their polyA tails they might bind nascent ORF2 proteins from LINE1 RNAs and force 
these proteins to induce the reverse transcription and integration of their RNA rather than 
LINE-1 mRNA. 
Repeats may be also be responsible for epigenetic control mechanisms, or other 
modifications of gene activity, based on modifications of the DNA itself rather than its 
sequence. It has been hypothesized, for example, that a repeat-induced process involving 
L1 retroelements might be responsible for the X-inactivation, a process necessary to 
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maintain proper gene dosage in females who have two X-chromosomes (Neumann et al., 
1995). 
It can happen very rarely that a conventional cellular mRNA is subjected to 
reverse transcription and transposition from an enzyme deriving from L1 or other 
retrotrasposons in which case the gene undergoes duplication. The new copy of the gene 
in this case will lack of its promoter region as well as its introns, and thus in most cases 
will lose its function, becoming a “processed pseudogene”. Processed pseudogenes are 
distinct from “ordinary” pseudogenes which instead derive from a duplication event of a 
whole genomic portion, and thus maintain their original gene structure comprising exons, 
introns, promoters and so on. Sometimes insertions can occur during this process 
disrupting the original function of the gene and causing a genetic disease. 
Elements encoding Transposase 
These elements belong to class II and comprise inverted repeats (10-500 bp) at 
their termini and encode trasposase which catalyzes trasposition. Following excision they 
shift elsewhere in the genome where they insert by a non-replicative mechanism. It has 
been shown that the human genome contains sequences originated from more than 60 
different DNA transposons. 
MITEs  
MITEs (miniature inverted-repeat transposable elements) constitute another group 
of mobile elements (Feshotte et al., 2002). They have short terminal inverted repeats, and 
their length is comprised between 125-500 bp. They were firstly identified in plants, and 
subsequently observed in mosquito, zebrafish and human (Dufresne et al., 2007). Their 
mechanism of transposition is still unknown, but they do not appear to be autonomous. 
                                                                                                                                                                                         INTRODUCTION  
 
 25 
MITEs appear to be preferentially associated with genes and thus might play a significant 
role in generating genetic variation (Dufresne et al., 2007). 
Effects of repetitive elements on gene expression 
Mobile elements and repetitive elements can alter the structure of the genome and can 
regulate gene expression of the genome in several ways. Firstly, as previously described, 
transposition may disrupt functional genes. Many transposable elements have a 
constitutive promoter that can drive an inappropriately expression of a gene downstream. 
On the other hand if the promoter of the transposable element is opposite with respect to 
a neighbouring gene, it can initiate transcription of an RNA transcript which is 
complementary to the gene mRNA, and thus disrupt the endogenous expression of the 
gene via antisense RNA mediated silencing.  
Pseudogenes 
Pseudogenes belong to the set of non-coding transcripts which are less likely to 
have a biological role (Cheng et al., 2005; Carnici et al., 2005). The cDNA collection 
obtained by FANTOM3 contains several transcripts that seem to encode for proteins, but 
which contain a few mutations disrupting the ORF, which could be considered 
pseudogenes. The definition of pseudogenes has been modified over time. Initially 
pseudogenes were considered genomic sequences which resemble functional genes, but 
which for some reason have been inactivated. As noted earlier, some derive from the 
insertion of mobile elements within open reading frames (ORFs) of functional genes, 
while others are the result of  “processed genes”, i.e. the sequence indicates that probably 
a retrotranscription event has taken place (with RNA being used as a template to make 
DNA) and has resulted in the re-integration of the generated DNA within the genome. 
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While the common view is that most pseudogenes do not perform a clear biological 
function but are, rather, evolutionary fossils, recent findings indicate that some are clearly 
functional (Hirotsune et al., 2003; Zheng et al., 2005), by binding transcription factors 
and impeding them from being involved in the activation of gene expression. 
Comparative genomics of non coding sequences 
One of the aims of genomics is try to understand how genomes are organized and 
in particular which sequences are involved in the complex mechanisms involved in the 
regulation of gene expression. The sequencing of a large number of genomes, in 
particular within the chordate subphylum, has lead to the utilization of comparative 
genomics techniques. The basic principle of comparative genomics is that of identifying 
portions of the genome whose sequence has changed significantly less than expected 
during evolution, indicating potential functional constraints and thus enabling us to 
distinguish potentially functional non-coding DNA from junk DNA. Generally speaking 
non-coding regions are less conserved than protein-coding genes. However, the first large 
scale comparative genomics analysis, which was done when the first draft of the mouse 
genome had become available, showed clearly that protein-coding sequences only 
account for approximately a fifth of the total amount the genome which is subject to 
purifying selection (International Mouse Genome Consortium, 2002), thus implying that 
a relatively relatively large amount of non-coding DNA is likely to be functional. These 
segments of highly conserved elements are usually embedded among large dissimilar 
segments producing a mosaic picture of genomic conservation.  
Studies of small genomic regions had demonstrated the possibility to identify putative 
genes as well as regulatory elements looking at cross-species conservation already prior 
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to the first drafts of entire genomes (O’Brien et al., 1999; Ansari-Lari et al., 1998). 
Comparative analysis between mouse and human genomes suggested that 5% of genomic 
DNA is under active selection which is likely to be associated with a functional role 
(Waterson et al., 2002). Many of these conserved regions correspond to protein coding 
exons, while the remainig sequences, generally called “conserved non-genic sequences” 
(CNG) or “conserved non-coding sequences”(CNS) (Hardison et al., 2000) seem to be 
involved in important regulatory activities (Dermitzakis et al., 2006). The latter constitute 
a significant portion of non-coding DNA and have become the focus of deeper 
investigations recently. Intriguingly it has been shown that CNSs represent only a subset 
of regulatory elements and at the same time only a subset of them are regulatory elements 
(Nobrega et al., 2003). In fact, only a fraction of these sequences can be associated with 
transcriptional regulation, such as enhancers (Nobrega et al., 2003; Bejerano et al., 2004), 
while it is not clear whether the rest of them bear a biological function. Supporting the 
notion that not all of these are directly related to the regulation of transcription of specific 
genes, it has also been observed that they are scattered along the genome independently 
of gene density (Dermitzakis et al., 2004; Dermitzakis et al., 2005).  
Evolutionarily conserved regions (ECRs) are found both in coding and non-coding 
regions and have been identified computationally comparing two mammalian genomes 
such as mouse and human and using a window of length 70-100 bp and a threshold of 
percentage identity ranging from 70% conservation (Loots et al., 2000; Dermitzakis et al., 
2003) to complete identity. Comparisons of the human genome against the genomes of 
distantly related vertebrates, moreover, have revealed an abundance of highly conserved 
non-coding elements (CNEs) (Boffelli et al., 2005; McEwen et al., 2006). Interestingly, a 
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property of human CNEs is that they cluster in genomic regions containing transcription 
factors and genes involved in the regulation of development (Bejerano et al., 2004; 
Woolfe et al., 2005; Vavuri et al., 2006). 
Although non coding sequences generally lack sequence conservation among divergent 
species (Thomas et al., 2003), comparisons between human and the Japanese pufferfish 
(Fugu rubripens) show that those non-coding elements which do present significant 
sequence conservation often also play a role in vivo (Marshall et al., 1994; Rowich et al., 
1998; Kammandel et al., 1999; Bagheri-Fam et al., 2001; Ghanem et al., 2003; Lettice et 
al., 2003; Nobrega et al., 2003; Santagati et al., 2003; Spitz et al., 2003; Kimura-Yoshida 
et al., 2004). The common ancestor shared by both Fugu and human lived about 450 
million years ago (Kumar et al., 1998), implying that sequences which show significant 
conservation between these two species, including non-coding sequences, are highly 
likely to play a role in vertebrate life. 
Verification of enhancer activity in vivo 
A general strategy to test whether non-coding regulatory sequences are functionally 
relevant involves assaying their ability to up-regulate (or down-regulate) reporter genes 
in vivo. “Enhancer” assays using transgenic animals, especially in the case of transgenic 
mice, are very slow, costly and laborious, but have so far been one of the main sources of 
data on the function of non-coding DNA around, in particular for developmental genes 
(Nobrega et al., 2003, Pennacchio et al., 2006). In recent years an alternative approach 
has emerged, which has proven to be very useful to tackle this issue, which uses transient 
expression assays in zebrafish (Brachidanio rerio) embryos obtained by co-injection the 
candidate enhancer sequence with a promoter/reporter construct in the fish (Muller et al., 
1997; Muller et al., 1999; Dikmeis et al., 2004). The zebrafish model presents on the one 
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hand a divergent genome suitable, although challenging, for comparative genomics 
analysis and on the other hand it is an extremely tractable experimental system. The 
experimental advantages are represented by the fact that a large number of fertilized eggs 
are available and easily modified by micro-injection, that the developing embryos are 
transparent and contain many easily identifiable cells, and finally that the detailed 
anatomical, physiological and developmental properties are known for many of these 
cells. Although the pattern obtained in this transient expression assays are mosaic, it is 
feasible to screen hundreds of individuals embryos at the same time, thus collating 
mosaic patterns into a final compound image. 
Non-coding RNA genes 
For several years molecular biology was based on the central dogma that stated 
that genetic information stored in DNA is transferred into RNA through transcription and 
is then finally decoded by translation of RNA into proteins. In this view RNA molecules 
played a passive role of mere messengers. Today it is well established that RNAs can 
play much more active roles within a cell and that several classes of RNA molecules exist 
which serve a function without encoding a protein message (Fig 7). RNAs can be thus 
divided into two main classes: messenger RNAs which are destined to be translated into 
proteins, and non-coding RNA (ncRNA), many of which are not well characterized yet, 
but which can be broadly classified as such because they generally do not encode for a 
protein. Non-coding RNA (ncRNA) transcripts are can play a multitude of roles, have 
their own structure and act as regulatory and/or catalytic molecules. Although the 
FANTOM3 project estimated that at least about 28,000 ncRNAs exist in mouse (Liu et 
al., 2006) the total number of ncRNA genes present in the mammalian genome is far 
                                                                                                                                                                                         INTRODUCTION  
 
 30 
from clear, let alone their function. It has been observed that a large portion of ncRNA 
transcripts have introns (Ota et al., 2004), which raises the possibility that the primary 
transcript could be inactive and the subsequent cleavage and splicing maybe required to 
generate an active RNA molecule. The nature of these molecules is quite variable (small 
or multicopy), and their conservation across genomes is rather poor, thus it is complex to 
detect them and annotate them appropriately. The size of ncRNA molecules is also 
extremely variable from some as small as 22-25 nucleotides (which is the case for 
miRNAs) to thousands of nucleotides (such as ncRNA involved in silencing) (Hutvagner 
et al., 2002). The processes in which they have been shown to be involved are wide, from 
transcriptional and post-translational regulation, to chromosome replication, mRNA 
stability, protein degradation and so on (Hutvagner et al., 2002; Brandl et al., 2002). Thus 
it is an entire new world, likely to be at least as complex as that of proteins, which awaits 
to be discovered. 
Functional genomics 
Using the transcriptome to annotate the genome  
Once the sequence of several mammalian genomes was completed unitil 
annotation tasks focused on the annotation of genes within the sequence, initially relying 
on mapping protein and cDNA sequences of known genes (which had be cloned in the 
past 50 years individually) and cDNA or EST sequences, as well as any other genes 
which could be predicted either by sequence similarity (for orthologs and paralogs in 
particular) or by ab initio gene prediction, which is based largely on the basic properties 
of coding genes (such as 3rd codon position degeneracy, ORF detection and hexamer 
statistics). As genome annotation developed so did genome browsers such as Ensembl 
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(http://www.ensembl.org/), the UCSC genome browser at the University of California at 
Santa Cruz (http//: genome.ucsc.edu), as well as the browser present at the National 
Center for Biothechnology information (http//: www.ncbi.nlm.nih.gov). These browsers 
are user friendly and allow users to scroll along the chromosome and zoom in or out to 
any scale, and display information at several levels of detail. 
Although these initial approaches were incredibly useful to provide a first 
annotation “map” of the genome (and they are still valid and utilized now) it quickly 
became apparent that a good annotation was heavily reliant on the datasets that were used 
to produce it and thus strong efforts were put in place to produce larger and more diverse 
datasets exploring the full functional potential of the genome. 
One of the widely tackled issue in an attempt to provide deeper functional annotation of 
the genome was that of characterizing comprehensively the transcriptome. The first 
approach which had a deep impact in this sense was the high throughput sequencing of 
cDNA ends (ESTs). The UniGene project (http://www.ncbi.nlm.nih.gov/UniGene) for 
example, assembled into clusters all available EST sequences creating a public database 
which, on the one hand was integrated in genome annotation pipelines, and on the other 
hand became a resource in its own right which can provide information, for example, on 
the relative tissue distribution of each cluster, yielding hints on the potential expression of 
a novel gene. An inherent disadvantage of this method is represented by the fact that 
while abundant transcripts have been sequenced thousands of times, many rare transcripts 
are completely absent from these EST databases, in particular those which are expressed 
only in very specific cell types, and are therefore very rare in whole tissue/organ libraries.  
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A similar approach has been developed based on the isolation and the sequencing 
of full-length cDNAs. The RIKEN Mouse Gene Encyclopedia Project, amongst others, 
has adopted this approach in a systematic manner providing a comprehensive dataset for 
the eukaryotic transcriptome. The RIKEN group used several complementary techniques 
to produce full-length cDNAs (Carnici et al., 2003). These techniques required (1) a 
novel reverse transcriptase reaction, (2) a novel 5’capture technology, (3) novel 
approaches to normalize and subtract cDNA libraries. Furthermore in order to fully 
annotate all the collected cDNAs, as well as to perform in-depth follow-up studies on the 
dataset an international consortium called FANTOM was put together. Initially, the 
consortium produced the FANTOM1 collection comprising about 21.076 cDNAs, and 
developed a simple web-based annotation interface for this dataset (Kawai et al., 2001). 
Already within the first collection it was observed that there was some redundancy in the 
set of cDNAs obtained (i.e. some clones were picked with different, but overlapping 
sequences). One of the causes identified was the high level of 3’ end variation (due to 
alternative polyadenilation/termination signals) in mammalian mRNAs. In this first round 
of the project a large number of clones remained “unclassified” because their annotation 
was not very clear at the time (due to the lack of an ORF, etc). The project was thus 
extended to shed further light on the data obtained. During Fantom2 an interface was 
created that became an all-online annotation system from remote sites via the Internet, 
through the “Mouse Annotation Teleconference for RIKEN cDNAs Sequences” 
(MATRICS). In this way, the knowledge of the mouse transcriptome was considerably 
extended, however the cDNAs collected still covered only half of all the genes predicted 
in the genome. Finally the collection was expanded utilizing a much larger number of 
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tissues and cell lines as RNA sources in the third round of the project, Fantom3. Fantom3 
was a major turning point for the project, as it became apparent that approximately half of 
the genome is transcribed into non coding transcripts, and that the genome is organized 
into transcriptional forests (TFs) comprising a multitude of coding and non-coding, sense 
and antisense transcriptional units (TU) and transcriptional deserts, which lack any 
evidence of transcription (Carnici et al, 2005).  
Interestingly, FANTOM3 also deployed several techniques complementary to the 
mere identification of full-length cDNAs, such as CAGE, a technique aimed at obtaining 
the first 20 nucleotides of all transcripts screened, which are then concatenated, much like 
in SAGE, and sequenced, thus enabling fast and cheap sequencing of a very large number 
of transcription start sites, yielding novel information on the usage and frequency of 
transcription start sites in the mammalian transcriptome. This and other complementary 
techniques used in Fantom3 clearly demonstrated that both transcriptional start sites 
(TSSs) and transcriptional termination sites exceeded the number of Transcriptional Units 
identified, thus underlining that the usage of alternative start and termination sites is yet 
another form of complexity embedded in the mammalian genome, despite the fact that 
the number of genes is that is very similar across vertebrates.  
The data obtained in recent years on transcriptional start sites allowed the 
development of novel algorithms aimed at transcription start site detection, such as 
EPONINE, a program which aims to predict the exact location of the transcriptional start 
site (TSSs) (Down et al., 2002) for a subset of genes. The TSS model utilized 
corresponds to the observation that promoters are often associated to CpG islands, as well 
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as specific motifs such as the TATAAA motif tightly distributed at position -30 relative 
to the transcription start site.  
As described earlier, it is now clear that a large part of the genome bears 
functional elements that escape the well-known rules of protein coding genes and often 
also those of transcription as a whole. Thus a recent project was developed to tackle this 
specific question, the ENCODE (Encyclopedia of DNA Elements) Pilot Project (The 
ENCODE Project Consortium 2004, 2007). The aim of the project is the mapping of all 
the varieties of features present in the genome, such as genes, promoters, enhancers, 
silencers or repressors, exons, replication origins and termination sites, as well as 
chromatin modifications, methylation sites, conserved sequences, etc. The ENCODE 
project provided the identification of novel TSSs as well as the arrangement of regulatory 
sequences and binding sites for transcription factors around TSSs (Denoeud et al., 2007, 
Trinklein et al., 2007; Xi et al., 2007; Zhang et al., 2007).  
How many genes? 
 Although the sequence of the human genome can be considered virtually complete, 
several debates have developed on the definitive catalogue of the genes that it contains. 
In fact, the rapid completion and the public release of the mouse and human genomes has 
led to a decrease of the number of genes predicted in the mammalian genome (Waterson 
et al., 2002). The Human Genome Sequencing Consortium estimates that the actual 
number of human genes is comprised between 20,000 and 25,000, strikingly lower than 
the early estimates of far more than 30,000 (Lander et al., 2001). For a long time the total 
number of genes has been a matter of debate; early estimates ranged from 28,000 to 
120,000 genes, based on expressed sequence tag (EST) clustering (Ewing et al., 2000; 
Liang et al., 2000). Today, thanks in part also to the Fantom3 project these large 
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discrepancies have been understood to arise from the distinction between loci (which are 
approximately 20,000) and the transcriptional forests contained within them (which 
contain over 100,000 transcripts), and the overall complexity attributed to coding and 
non-coding transcripts, alternative splicing, alternative transcription start sites, etc. 
Before a large number of full-length cDNA sequences became available, each appeared 
as a distinct entity, rather than as a part of a complex transcriptional forest, thus 
impacting erroneously gene counts.  
Functional genomics: characterizing gene function 
The massive increase in sequencing projects allowed to rapidly expand the realm 
of both cDNA and genomic DNA information. It quickly created a gap, however, 
between the rapid discovery of genes and the slow process of actually identifying their 
function both within a physiological as well as, importantly, a pathological context. Thus, 
it became crucial to tackle this information gap and, to this end, scientists developed 
novel functional genomics strategies to develop experiments designed to discover and 
characterize the function of novel genes in a reasonably high throughput manner.  
Several strategies were thus devised to identify, isolate and characterize genes by 
disrupting their function and observing the phenotypes induced. Some of the techniques 
developed are enhancer and promoter traps (Friedrich et al, 1991), gene traps, random 
activation of gene expression experiments (RAGE) as well as genome-wide cell-based 
knockout (GECKO). Finally, owing to gene-targeting techniques, transgenic mice have 
also proven crucial for the understanding and evaluation of gene function as well as to 
develop models of human disease based on specific single or multiple gene knock-outs.  
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Gene trapping  
High-throughput gene trapping is a random approach for inducing insertional 
mutations within the genome; in recent years, this technique has become very important 
to study development exploiting the use of embryonic stem (ES) cells in vitro and in vivo. 
The principle behind gene trapping is essentially the random insertion of a DNA vector 
designed so that if the insertion happens within an existing gene locus its activation is 
detected via a reporter gene embedded in the vector. Gene trap vectors simultaneously 
inactivate and report the expression of the trapped gene at the insertion site, as well as 
providing a DNA tag for the rapid identification of the disrupted gene. 
Three main types of entrapment vectors have been described: (1) enhancer trap 
vectors, which have to be integrated near an endogenous enhancer in order to activate the 
reporter gene that is fused to a minimal promoter (Bellen et al., 1996) (2) gene trap 
vectors, which need to integrate within an already actively transcribed gene in order to 
work and (3) promoter trap vectors which also need to integrated within an existing gene, 
but since the vector bears also a promoter, the gene does not necessarily need to be 
active. The principal element of all gene trapping vectors is a gene trapping cassette 
consisting of a reporter gene and/or a selectable marker gene flanked by an upstream 3’ 
splice site (splice acceptor (SA)) and a downstream transcriptional termination sequence 
(polyadenylation sequence (polyA)). When inserted within the intron of an expressed 
gene, the gene trap cassette is transcribed from the endogenous promoter in the form of a 
fusion transcript in which the exon(s) upstream of the insertion site is spliced with the 
reporter/selectable marker gene. Since transcription is terminated prematurely at the 
polyadenylation site contained within the vector, the processed fusion transcript encodes 
a truncated and non-functional version of the cellular protein as well as the 
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reporter/selectable marker (Stanford et al, 2001). When gene traps are introduced into ES 
cells, they integrate more or less randomly across the genome, although some preferential 
trapping events are known to occur (Durick et al, 1999; Skarnes et al, 1992; Skarnes et al, 
1995; Von Melchner et al, 1992). Antibiotic resistant ES cell colonies are easily selected 
and expanded in vitro, and clonal cells can be isolated for injection into mouse 
blastocysts or differentiation in vitro. Expression of the gene trap is assayed for reporter 
gene expression (e.g. β-galactosidase activity), and staining is indicative of an insertion 
event. The transgene is only activated when it integrates correctly within a transcriptional 
unit; however it is known that some translation fusions (frameshifts) inactivate the 
reporter activity or may target the translated proteins into subcellular location where 
reporter activity is not easily detectable.  
The possibility of developing mice derived from these “trapped” ES cell lines 
have permitted the identification of many novel developmentally regulated genes with 
specific spatio-temporal expression patterns as well as a better characterization of known 
genes. By selecting for the activation of the reporter gene in cell culture, the rate of gene 
disruption in recovered clones approaches 100%, and the random insertion of exogenous 
DNA into single sites in mammalian genome (gene trapping) provides a genome-wide 
strategy for functional genomics. ES cell cultures thus provide a simple model system for 
studying the genetic pathways that regulate embryonic tissue development and permit 
high-through-put screening of clones for tissue restricted gene trap expression (Bonaldo 
et al, 1998).  
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Stem Cells as a model for transcriptome characterization 
Embryonic stem cells can be maintained in culture as totipotent cells (i.e. cells 
that can give rise to all type of cell lineages) under appropriate growth conditions and can 
be easily genetically altered. ES cells are one of the richest sources of transcriptional 
diversity; in fact they are known to express (at low levels) the majority (60%) of known 
genes, probably in relation to their pluripotent state, as though many genes were ready to 
be upregulated depending on which differentiation stage is undertaken. On the other hand 
these cells are also known to have a set of genes expressed at significant levels which are 
likely to be responsible for their “stemness” phenotype. The recent advances made by 
Fantom3, furthermore suggest that probably many other unique transcripts, either entirely 
novel, or derived from splice variants of known ones, are likely to be also involved and 
probably remain to be identified.  
It is worth noting also that although the sequence tags obtained from trapping 
experiments in ES cells are similar in quality to ESTs (i.e. short, single pass, low quality 
reads of sequence in most cases much shorter than the transcript they are derived from), 
they are quite different in nature. ESTs derive from cDNAs and have therefore specific 
biases attached to the method utilized to obtain them. For example they are usually only 
5’ and 3’ ends of full-length transcripts, and their detection is highly dependent on 
transcriptional levels. Sequence tags derived from gene trapping experiments are only in 
part dependent on transcriptional levels (since some vector are able to trap genes that are 
not expressed in ES cells), and derive directly from a genomic integration of the vector. 
Interestingly, several preferred integration sites, or “hot spots” have been observed 
(Hansen et al., 2003). Moreover, it has been demonstrated that these gene trap hot spots 
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are not sequence specific and are not related to gene size, suggesting that they are defined 
by secondary chromatin structure (Hansen et al., 2003).   
 Bioinformatics-based approaches have accelerated the evaluation of mutant 
clones (originated by gene trap, RAGE and GECKO experiments) leading to the rapid 
identification of informative cell lines on an unprecedented scale. The combination of 
this resource with other large-scale approaches including bioinformatics, expression 
profiling and in situ hybridizations just to name a few, is a powerful tool which enables to 
quickly provide some hypothesis with regards to the specific biological process or disease 
state with which a novel gene might be associated, thus providing a clue for further 
testing. For example, a sequence tagged gene-trap library of > 270,000 mouse ES cell 
clones has recently been developed and has been employed together with a functional 
screen of knock-out mice to identify genes regulating blood pressure (Friedel et al., 2005) 
(e.g., http://baygenomics.ucsf.edu/overview/welcome.html). Efforts are also underway to 
make ES cell lines with gene traps freely available for researchers so that transgenic mice 
containing a potential gene of interest can be made to further understand the role of 
specific genes in development and disease (Skarnes et al., 2004). 
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Aims of the thesis 
The completion of the sequencing and annotation of the mouse genome (Waterson 
et al., 2002) suggested that the understanding of the number and the function of most 
genes in the genome would be accomplished swiftly. Recently the FANTOM Consortium 
has demonstrated quite evidently that the annotation of the genome is far from being 
completed. Quite on the contrary Fantom has demonstrated that the genome is organized 
into transcriptional forests, that present a complex array of sense and anti-sense, coding 
and non-coding transcripts (Carnici et al., 2005) and that we only begin to understand the 
multi-dimensional complexity which is overlaid on the mono-dimensional layer of DNA 
sequence. 
In our study we have used data derived from a gene trapping approach in mouse ES 
cells to re-annotate the mouse genome as well as shed light on gene trapping hot spots. 
Stem cells express a large number of transcripts at low levels, which are “dormant” ready 
to be activated upon differentiation. They also express a set of genes, some of which have 
still unknown function, at significant levels, likely to be involved in maintaining the 
“stemness” state (Boheler et al., 2003). Althrough gene trapping is not a novel resource, it 
has not been used extensively in the context of genome annotation, and with this work we 
demonstrate that it is indeed a very significant source of data to identify novel novel 
features of the mouse genome as well as to characterize further the genes involved in the 
“stemness” phenotype.  
In the second part of this work we investigated the function of specific non coding 
elements that shows a conservation across divergent organism. We found that the 
majority of these elements undergo shuffling across evolution (thus they were called 
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shuffled conserved elements, SCEs) and we prove that the majority of them act 
successfully as enhancers in vivo. 
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Figure 1. Re-association kinetics. 
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Figure 2. Fractions of different sequences in the human genome. 
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Figure 3. Several transcript variants generated by different alternative splicing 
events. 
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Figure 4. Schematic representation of a nested gene.  
The gene is in the same direction of the gene X but is completely contained within its 
introns. 
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Figure 5. Classes of interspersed repeats in the human genome.  
Blue rectangle: promoter; red block: LTR (long terminal repeat); triangle: short terminal 
repeat. 
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Figure 6. Different modes of transposition. 
The class I mobile elements (non-LTR elements) uses an RNA intermediate to reproduce 
itself (shown on the left panel). The class II mobile elements move by a conservative “cut 
and paste” mechanism (shown on the right panel). 
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Figure 7. Non-coding RNA transcripts. 
Micro RNAs and antisense RNAs are underestimated. Other non-coding RNAs are not 
present. (Taken from Human Molecular Genetics 3/e). 
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Figure 8. The basic trap vectors. 
Enhancer-, gene-, and promoter-trap vectors contain a LacZ reporter gene and a 
neomycin resistance gene (neo) that is driven by an autonomous promoter, are shown 
trapping an endogenous gene “X”. Integration of the trap vectors into the ES cell genome 
will lead to neomycin selection whether the insertion has occurred inter or intragenically. 
A) The enhancer trap vector contains a truncated heat-shock inducible 
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minimum(hsp68)promoter upstream of LacZ. The insertion of the vector close to the 
enhancer of the gene X will lead to the transcription and translation of the LacZ reporter 
when the enhancer of gene X is activated. B) The pGT4.5gene-trap vector contains a 
splice acceptor (SA) site immediately upstream of a promoter less LacZ gene. Its 
integration in an intron leads to a fusion transcript generated from the upstream exon of 
gene X and LacZ upon transcriptional activation of gene X. C) The promoter-trap vector 
needs to be inserted into the coding sequence of gene X to activate transcription of the 
LacZ. On activation of gene X, a fusion transcript and protein between the upstream gene 
X sequence and LacZ will be generated. 
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MATERIALS AND METHODS 
RNA extraction from ES cells 
 
RNA was extracted from ES cells using the Trizol reagent (Invitrogen). Cells were 
plated on 100 mm dishes. 48hrs later cells were washed with PBS. After washing the 
cells were resuspended in 1 ml Trizol reagent. The samples were maintained at room 
temperature for 3 minutes. 0.2ml of chloroform/ml Trio, were added, the samples were 
mixed gently, and they were maintained for 10 minutes at room temperature. The 
resulting solution was centrifuged at 14,000 rpm for 15 minutes at 4°C. The supernatant 
was discarded and the pellets were washed with 1 ml 75% ethanol. After washing the 
samples were air dried for about 10 minutes. The pellets were than resuspended in proper 
amount of DEPC treated water.  
DNase digestion 
The RNA samples were treated with 10 U DNase I (Ambion) per ml RNA sample 
at 37°C for 30 minutes. The digested samples were treated with a DNase. RNA was then 
checked on 0.8% agarose gel and quantified by measuring the absorbance at 260 nm. An 
absorbance of 1 unit at 260 nm corresponds to 40 µg of RNA per µl. 
cDNA transcription 
cDNA synthesis was performed using the SuperScriptTM First-Strand Synthesis 
System for RT-PCR (Invitrogen). cDNA syntesis was performed using random hexamers 
as follows: 
RNA   1µg  
Random hexamers             0,5µl 
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10mM dNTP mix  1 µl 
DEPC-treated water to 10 µl 
Each sample was incubated at 65°C for 5 min and incubated on ice for 1 min. 
Then 9 ml of the following reaction mixture were added to each sample: 
10X RT buffer 2 µl 
25mM MgCl2 4 µl 
0.1M DTT  2 µl 
RNase inhibitor 1 µl 
Samples were incubated at 25 °C for 2 min, and then 1 ml of SuperscriptTM II RT was 
added to each tube. Samples were then treated as follows: 
42°C for 50 min 
70°C for 15 min 
Samples were then chilled on ice and treated with 1 ml of RNaseH at 37 °C for 20 min. 
The cDNA synthesized in this manner was used as template in PCR experiments. 
The PCR mixture was prepared as follows: 
Buffer10X                      5µl 
MgCl2   25 mM              3µl 
dNTPs  5 mM                2µl 
Primer Fw  10 µM         2µl 
Primer Rv   10 µM        2µl 
Takara la Taq ( ~ 5 U )               0,4 µl 
RNA ( 50 ng – 100 ng ) 
Add sterile H2O to a final volume of 50µl. 
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Program 
 
1. 65 °C    for  10 min 
 
2. 95 °C    for  1min 
3. 58 °C    for  1min                
4. 72 °C    for  1min 
 
repeat for 35 cycles steps from 2 to 4. 
 
5. 72 °C    for  7min 
 
6. 42 °C  for  60min  
7.  70 °C   for  15min. 
Analyse the PCR product by gel electrophoresys. 
 Real Time quantitative PCR 
A 2x PCR supermix from Bio-Rad (iQTM SYBR® Green supermix) containing Taq 
DNA polymerase (iTaqTM polymerase), MgCl2, dNTPs, SYBR® Green, and fluorescein 
was used. Primers were added to the reaction mix at a final concentration of 400 nM. 1 
micro g of total RNA purified from ES cells and DNase digested was reverse transcribed 
as previously described. The cDNA was added at a dilution of 1:3. For each sample, three 
distinct amplifications were carried out in parallel. The real-time quantitative RT-PCR 
was performed using an iCycler iQ system (BioRad). Cycling conditions were: 3 min at 
95° followed by 40 cycles of 10 sec at 95°, 30 sec at 60° and 45 sec at 72°. The 
fluorescence data used for quantization were collected at the end of each 72°C step, and 
the treshold cycle (ct) was automatically determined using the accompanying iCycler iQ 
software by calculating the second derivative of each trace and looking for the point at 
maximum curvature. GAPDH was used as a reference gene. 
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Agarose gel electrophoresis 
Agarose gels (1 % w/v in TAE; 40 mM Tris-acetate pH 7.5, 2 mM EDTA) were 
prepared and supplemented with ethidium bromide (ca. 1 µg/ml). The percentage of 
agarose in gels was determined depending on the size of the DNA fragments to be 
resolved. Gels were generally run at 120 V in 1x TAE buffer, and DNA was visualised on 
a UV transilluminator. 
DNA sequence analysis 
For DNA sequence analysis, 100 ng of the PCR products were air dried and sent for 
sequencing. 
Isolation of DNA from agarose gels 
Following agarose gel electrophoresis, DNA gel slices were excised under UV light. 
DNA was extracted from these gel slices using Qiaquick columns (Qiagen) following the 
gel extraction protocol supplied by the manufacturer. Purified DNA was eluted from the 
columns using 30-50 µl of deionized water. 
 
Cloning of the PCR products 
2ml of the PCR product was added at the following mixture: 
1ml of TOPO salt solution 
0.25 ml TOPO vector  
2.75 ml sterile water 
The mixture was incubated for 30 minutes at room temperature. During this step an 
aliquote of competent XL1 blue bacteria (strain suitable for blue/white screening) was 
thawed on ice. The TOPO ligation was chilled on ice for 5 minutes, then 4 µl of this 
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ligation was transformed by heat shock into competent cells. The transformation was 
spread on to LB + amp plate. 
In vitro transcriptionMaterials 
- DNA template (purified PCR product or linearized plasmid) 
- DIG RNA Labelling Mix (Roche) 
- Ribonuclease inhibitor (Fermentas) 
- RNA polymerases  
Sp6 (New England Biolabs) 
T7 (New England Biolabs) 
T3 (Stratagene) 
- 10x transcription buffer (supplied with the RNA polymerase enzyme) 
- DNase I, RNase-free (Roche) 
- 1.5ml safe-lock, RNase-, DNase-, ATPase-free microtubes (Eppendorf 
Biopur) 
- 0.3M MgCl2 (it is practical to prepare a 3M stock solution and dilute 1:10 
before using) 
- 4M NH4Ac, autoclaved (keep at –20°C) 
- 100% Ethanol (keep at –20°C) 
- 70% Ethanol (keep at –20°C) 
- DEPC-treated water 
In vitro transcription 
The following mixture was prepared per reaction: 
20 µl of DEPC treated water 
2 µl of 10x transcription buffer 
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2 µl of 10x DIG RNA labelling mix 
1 µl RNase inhibitor 
1 µl RNA polymerase (T7 or SP6) 
1µg of linearized DNA plasmid. 
Samples were incubated at 37°C for 2.5 hrs. In the meantime, the Stop Solution was 
prepared as follows: 
16.4 µl of DEPC-treated water 
1.6 µl of MgCl2 (0.3 M) 
2.0 µl of DNase I (10 U/µl) 
1µl Stop Solution was added per reaction. This aids to stop the IVT and remove the DNA 
template. 
Samples were incubated at 37°C for 15 min. 
Precipitation of RNA 
To precipitate the RNA 72 µl ice-cold NH4Ac (4 M, autoclaved) and 470 µl ice-cold 
100% EtOH were added.  
Samples were placed at –80°C for 20 min, than centrifuged at max. speed in a table-top 
microcentrifuge (e.g. 13,000 rpm) at 4°C for 20 min. Supernatant was removed carefully 
making sure not to disturb the pellet. The pellet was washed with 640 µl 70% EtOH, then 
centrifuged at maximum speed at 4°C for 20 min. Then the supernatant was removed 
carefully. The pellet was dried in a vacuum centrifuge for approx. 6 min to eliminate 
ethanol residue which may interfere in later reactions. 
The pellet was re-suspended with 22 µl DEPC- H2O shaking (in horizontal shaker) 
at 1150 rpm for 15 min (room temperature). 
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Quality control and quantification 
Samples were checked on a 1% agarose gel. 1 µl riboprobe was added at 4.0 µl DEPC-
H2O and denatured for 5 min at 70°C. 
The samples were chilled on ice for 3 min, and 1 µl 6x loading buffer was added to each 
sample. Then samples were loaded on a 1% agarose gel and an electrophoresis was run. 
1µl of probe was diluted 1:100 (in Tris-buffer) and its concentration was determined 
using a spectrophotometer (A260/280). 
[ng/µl] = (A260)x(dilution factor)x(40). Concentrations between 500 – 850ng/µl are usual. 
Prior to using for in-situ hybridization, riboprobes are further diluted to a concentration of 
 
 30 ng/µl in hybridization-mix and stored at –20°C for a maximum of 2 months. 
Digoxigenin in situ hybridization 
Preparation of tissues: 
Wash the embryos in cold PBS, then transfer to fresh 4% paraformaldehyde/PBS at 4°C 
over night. Then transfer to 30% sucrose /PBS until they reach the bottom of the solution. 
Transfer embryos to a mixture of 30% sucrose/PBS and OCT at a 1:1 ratio agitating gently 
for 2 hrs at RT. Trasfer embryos to chilled OCT and freeze on dry ice. Store the sample at 
-80°C.   
Preparation of sections: 
10µm cryosections were collected on superfrost plus slides, the section were dried 
overnight at RT, and used the next day. 
Pretreatment and hybridization: 
Fix in fresh 4% PFA at RT for 15 min. Wash in PBTfor 5 min at RT. Bleach with 6% 
H2O2/PBT for 5 min at RT. Wash 3x PBT at RT for 5 min. Add 1 µg/ml proteinase K/PBT 
for 15 min at RT, then wash the embryos sections with fresh 2 mg/ml lysine /PBT for 10 
                                                                                                                                                                MATERIALS AND METHODS  
 
 58 
min at RT. Wash 3x PBT. Prehybridize at 65°C for 1 hr. Hyb at 65°C overnight in closed 
containers. 
Replace the slides in prewarmed (at 65°C) the sol1 (phormammehyde 50%/SSC/ SDS) for 
15 min at 65°C. Repeat the wash in sol3 for 3 times. Wash in TBST for 10 min at RT. 
Block in 10% sheep serum/MABT for 1hr at RT. Incubate with anti-digoxigenin antibody 
(1:2000) in 1% sheep serum/MABT at 4°C overnight. 
The morning after wash for 4 times in TBST for 15 min at RT. Then wash with NTMT at 
RT for 10 min. Incubate with NBT/X-phos in NTMT in the dark looking at the signal. 
Wash twice with NTMT at RT for 10 min. Then wash in PBS1X at RT for 5 min for two 
times. Put the samples in 4% PFA for 30 min a RT. Finally wash for 5 min in PBS1X. 
Repeat the washing. Section were mounted using Glycerol 70%/PBS and examined with 
an Axioplan microscope (Zeiss) equipped with an Axiocam CCD camera and Axiovision 
digital imaging software (Zeiss). 
 
Obtaining zebrafish embryos 
Natural cross fish 
The afternoon before the cross set up fishes. Place a smaller plastic container with a 
mesh bottom into a larger container. Add fish water to cover for some inches of water the 
mesh. Transfer a pair of fishes into the container. After the light comes on wait a bit and 
then cross the fishes. The onset of light is a major stimulus for zebrafish to breed. Collect 
the eggs from the bottom container. After the egg collection, separate the embryos and 
wash them in a Petri dish. The fish may lay a larger number of eggs comprised between 
30-50 eggs. 
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Removing the chorion 
Transfer the embryos using a plastic pipette. The embryos are still in their chorions. 
The chorions removal occurs pretreating the embryos with 0.5 ml of a 10 mg/ml pronase 
in water for 1min in a Petri dish. It’s important watching the embryos.  As soon as their 
chorions start to bubble change Petri dish. Stir gently. Thus, when the first 3-5 embryos 
are released from their chorion decant the content into a 500 ml backer filled with fish 
water. Now the embryos are extremely fragile. Repeat the washing for two times. 
 Once chorion is removed put the embryos using a plastic pipette in agar coated 
Petri dishes cause the embryo have to stay away from water and plastic surface cause 
they could explode. 
Preparation of the injection solution 
Purify PCR fragments using the Qiagen PCR purification kit. Run a 1% agarose gel 
and quantify the PCR products. The injection solution have to contain 1/10vol of phenol 
red DNA fragments at a concentration of 50 ng/µl reaching a range of 5 to 1molar ratio 
with the HSP LacZ fragment. 
Centrifuge for 2 min at maximum speed the injetion solution in filter column 
contained into a sterile eppendorf tube to remove particle debris that could block 
injection needles. 
Microinjection of early embryos (1-2 cell stage) 
Use a needle puller to prepare glass microcapillary needles. 
Add 1 µl of injection solution using a pipette in microfilament containing needles. 
Set presure conditions for injection: Pressure 10-200 psi, time: 0.3 ms. 
Place embryos in agarose plate in 10 Hank’s solution under the stereomicroscope. 
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Place needles into the embryo without shaking. Inject a drop with a diameter 
approximately 1/10th of the diameter of the animal pole of the embryo. For injection use a 
pedal (Narishige Harvard  Scientific). 
Put the embryos at 28°C to let them to develop. After 4 hrs look at the embryos and 
remove the ones that develop abnormally. 
LacZ staining 
After 24 hrs place the embryos into a 24 well plate in Hank’s buffer. Then replace 
the Hank’s buffer with a BT-Fix and let the embryos stay at 4°C in BT-Fix for 4 hrs. 
Then wash 3-5 times. Wash for 5 min with the Staining Buffer. Use 1 ml Staining Buffer 
+ 5µl 8% X-Gal in DMSO for the staining. Wash the embryos for 3 times with PBS/ 
0.02% NP40. Fix over night with BT-Fix at 4°C.Wash them again in PBS/ 0.02% NP40. 
Draw the expression maps. 
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RESULTS 
Background  
 
One of the aims of this thesis was the identification of novel genes using gene 
trapping as a novel approach to re-annotate the mouse genome.  
To start identifying novel genes 249,827 traps were collected from several public 
and private gene trapping projects found within the GSS section of GenBank. Among 
these sequence tags, 95.2%, defined as “mRNA traps”, were obtained by 5’- or 3’- 
RACE-PCR of the fusion transcript between the reporter gene and the endogenous gene 
while remaining sequences, named “genomic traps”, revealed the exact genomic insertion 
site because the sequence was obtained by inverse-PCR.  
These sequence tags were mapped to the genome using a stringent pipeline. This 
analysis showed that while 65% of them found a clear localization in the genome, 26% 
presented an ambiguous mapping that maybe due to the poor quality of the sequences, 
and the remaining 9% did not find any mach in the genome. In fact in most of the cases 
(43%) traps had a sequence length shorter than 50 nucleotides, making it difficult to 
assign them to an exact genome location. Other reasons that explain the lack of mapping 
for the remaining 5% of traps are the presence of spurious sequences in the data set as 
well as genome coverage issues. 
Traps were subsequently assembled on the basis sequence overlap: if two traps 
overlapped on the same strand of a chromosome by at least one base pair, they were put 
together in a cluster (named hereon “trapclusters”). About 12,509 traps indicated spliced 
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transcripts and were used to verify the presence of canonical splice site junctions in order 
to have some indication of the existence of a putative gene.  
In order to investigate if these sequence tags are able to detect novel genes they 
were compared with available collections of transcribed sequences, such as FANTOM3, 
based on full-length cDNAs (Carnici et al., 2005), and Unigene, which is based on 
clusters of EST sequences (Schuler et al., 1997). Interestingly trapclusters presented the 
highest proportion (40%) of unique sequences among the three data sets. This result 
suggests that the ES cell transcriptome might contain additional information, e.g. 
molecular features specific to their totipotency state, which are quite different from those 
obtained by FANTOM3 and Unigene in different tissues and cells. Comparing our 
dataset to the RefSeq database we observed that 44% of the trapclusters overlapped with 
a known RefSeq gene. Moreover, among those which do not overlap RefSeq, 9% 
overlapped with genes predicted by Ensembl but not found in RefSeq, a further 7% with 
cDNAs identified by Fantom3 and not present in Ensembl, and finally a further 2% with 
EST clusters contained in Unigene but nor present in the above datasets. Overall 38% of 
the trapclusters identified indicate novel putative features of the transcriptome that have 
never been annotated before. 
Novel exons within known genes 
Having mapped our dataset to the genome, and having identified a subset which did 
not overlap known gene databases we investigated whether this dataset was in fact adding 
novel putative exons to currently annotated RefSeq genes, which would better refine their 
currently annotated structure, taking into account that RefSeq contains curated gene 
structures which have been verified experimentally. We therefore investigated trapcluster 
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sequences showing a partial overlap with current RefSeq gene structures that could 
indicate novel potential exons. The analysis identified internal exons, as well as 5’ and 3’ 
exons on 830 RefSeq genes (Fig. 9). In order to verify the existence of these candidate 
exons, we chose 40 of these and we performed RT-PCR experiments using as template 
ES cell RNA to verify the expression of these exon.  
In these experiments we decided to project a primer on a candidate exon and a 
primer on the closest exon belonging to the annotated gene. We confirmed the existence 
of the predicted exons in 40% of the cases. Furthermore we verified if these novel exons 
were specifically expressed in ES cells or whether they could constitute alternatively 
spliced exons which would occur only in specific tissues. For this reason we performed 
the same RT-PCR analysis using total RNA extracts from several mouse tissues, i.e. adult 
brain, eye, heart, and whole embryo at 14.5 days of development (E14.5). This additional 
verification confirmed that indeed these exons presented complex patterns of splicing, but 
also showed that some exons which are trapped in gene trapping experiments are not 
necessarily expressed at detectable levels in ES cells. This additional verification 
confirmed as expressed a further 30% of the exons predicted. Thus the compound result 
of these verifications, taking all tested tissues into account, yields an overall success rate 
of 70% (Table1). Table 1 shows all the exons which were tested by RT-PCR across 
different RNA samples. This test allowed us to group exons in different categories 
depending on their expression pattern. Exons which were found to be expressed only in 
ES cells were named “ES-only”, those which were expressed in all tissues tested were 
named “ubiquitous”, those which showed a complex on-off pattern of expression and 
different amplification products of several lengths depending on the RNA used were 
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named “complex”. Finally the category named “ES-absent” comprises 12 exons which 
could not be detected in ES cells. Six of these exons were trapped using a polyA-type 
vector which is able to trap genes even if they are not transcribed in ES cells, and the 
other six were trapped by an SAbgeo-type vector, thus they are probably expressed at 
very low levels in ES cells and are up-regulated upon differentiation. The last group was 
named “absent” as it contains exons which could not be verified in any of the RNAs 
tested. We cannot exclude that these exons could be real and could be expressed in 
tissues/stages which we did not test These data taken together demonstrates that gene 
trapping is able to capture both expressed and non-expressed genes, depending on the 
type of vector used. Figure 10 shows some examples of known genes to which our 
analysis added novel exons. For example, an alternative 5’UTR exon was added to the 
known Ncapg2 gene (Fig. 10 A), which shows a complex expression pattern, since it 
appears to yield several splicing variants depending on the RNA sample used. Similarly 
trapcluster TCL606 (Fig. 10 B) indicates a new 5’UTR exon within the Niban gene, 
which is expressed in a stage specific manner, as a clear band can be observed in ES cells 
and in whole embryo, while in other tissues it is not possible detect any signal.  
In the case of trapcluster TCL195 (Fig. 10 C), we verified the addition of a novel 
internal exon between exon 3 and exon 4 of the known gene Nol1 and it was found to be 
expressed in all samples tested, giving always the same product length. This suggests that 
there is an alternative transcript of Nol1 containing this novel exon that had not been 
observed before. On the contrary, the addition of a new exon to the Inpp5d gene occurs 
only in ES cells among the samples tested, suggesting that this alternative transcript 
could, perhaps, have a specific role in ES cells.  
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A further group of exons tested fell in the 3’UTR of known genes (Fig. 10 E, F). 
The TCL10445 cluster (Fig. 10 E) seems to add a 3’UTR exon to the Rhebl1 gene. 
However, when sequencing this alternative product we realized that the resulting 
transcript, which does include this novel exon, skips the last two exons of the gene in all 
RNA samples, except in whole embryo. Finally we also show the addition of a 3’UTR 
exon to the Bcl7c gene. This exon is expressed only in ES cells and is located quite far, at 
a distance of 30 kb from the last known exon of the gene. 
Identification of Novel Transcripts 
We observed that a large number of trapclusters (~66%) did not overlap with other 
clusters or known genes, so it was difficult hypotesize the start and the end of a putative 
gene embedding the trapcluster. Thus we used CpG islands and transcription start sites 
(TSS) predicted by Eponine (Down et al., 2002) to define potential gene boundaries 
around trapclusters, to reduce this large data set into a lower potential number of novel 
genes. In this way, it was possible to group adjacent (but not overlapping) trapclusters 
into a set of about 8,420 novel transcripts classified into 1,997 “novel genes” (found in 
regions between CpG islands whithout any annotation) and 6,423 “novel transcripts” 
located within known transcriptional forests (Fig. 11). About 1,333 are “nested”, that 
means that these gene are in the same direction of a known transcript within the locus but 
are completely contained within its introns, while 792 were considered putative 
“antisense transcripts” because they have an orientation that is opposite with respect to a 
known transcript. 
We choose 80 random transcripts (1%) from this reduced dataset and we proceeded 
to verify their existence as well as that of all of the exons contained within them by RT-
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PCR experiments. We found that 71% of these genes (57/80) are expressed in ES cells 
(Table 2), and we also confirmed that 50% of their exons are expressed in ES cells. As a 
negative control we performed 10 RT-PCRs using 20 existing trap primers assorted 
randomly while as a positive control we performed a similar analysis using primers for 
trap TCLG4070. While the positive control was confirmed, all other primers gave 
negative results.  
Fig. 12 A shows an example of the results obtained, indicating the TCLG1417 
transcript, which lacks an ORF, thus probably a non-coding gene. Interestingly, this novel 
transcript was identified to be in opposite orientation and partial overlap with respect to 
the known gene Trpm3, indicating a potential regulatory role. This new non-coding gene 
was predicted to have 10 exons and our RT-PCRs confirmed 7 out of 10 of these exons as 
truly expressed in ES cells.  
Another predicted transcript which was found in reverse orientation with respect to 
a known gene is TCLG1647. In this case, the predicted gene is actually larger than the 
known gene (Tcf15) which is fully contained within one of its introns. This gene also 
appeared to contain 7 exons, but the PCR analysis showed that among the predicted 
exons two proximal exons form, in reality, one larger exon. Moreover, the sequence data 
brought about the addition of yet another exon that was not present in the trap collection 
as well as two separately expressed exons that could not be linked to this transcript. 
TCLG400 (Fig. 12 C) is found in opposite orientation and partial overlap to the 
Ngfr gene. It is composed by 4 exons, which were all confirmed by RT-PCR. TCLG1753 
(Fig. 12 D) is a single gene, antisense to the Prkci gene, in which we confirmed 3 out of 5 
predicted exons. We also confirmed all five exons predicted for the TCLG2423, three of 
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which show a partial overlap with the 1110032016Rik gene. Finally Fig. 12 E shows the 
TCLG4470 gene, which contains 3 exons and is found in opposite direction and fully 
contained (i.e. nested) within the intron of the Oprd1 gene. 
Expression profiling of a non-coding transcript. 
In order to verify further the expression of non-coding transcripts within our data 
set, we performed an in situ hybridization of one of the transcripts verified by RT-PCR, 
TCLG1417, the non-coding gene antisense of Trpm3 described above (Fig. 12 A), on a 
mouse embryo at 14.5 days of development. This developmental stage is very 
representative because it represents an interesting temporary window in which a large 
number of genes are expressed. The results from the in situ hybridization indicated a very 
specific pattern of expression in the inner ear (choclea and vestibules), in the choroid 
plexus and in the eye (Fig. 13). The same expression pattern was obtained in E12.5 
embryos and in P0 mouse (data not shown).  
These data led us to hypotesize that this novel transcript could act as antisense 
regulating the mRNA stability of the Trpm3 gene. Trpm3 is a poorly understood member 
of the large family of transient receptor potential (TRP) ion channels. In literature five 
splice variants have been reported. In situ hybridization experiments conducted on this 
gene showed that Trpm3 is expressed in several regions of the mouse brain such as the 
dentate gyrus, the intermediate lateral septal nuclei, the indusium griseum, and the tenia 
tencta (Oberwinkler et al., 2005) and northern blot analysis confirmed expression also in 
the eye. Interestingly, strongest expression was observed in epithelial cells of the 
choroids plexus. Further experiments will be focused on understanding the function of 
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this novel gene, its possible role in the auditory pathways as well as its potential 
interactions with the Trpm3 gene.  
Trapping of genes correlates with their expression levels 
Although the majority of genes is trapped only once or very few times, a small 
subset of genes is trapped hundreds of times. Therefore we decided to investigate whether 
this subset of genes also displays significantly higher levels of expression in ES cells. 
One factor that could theoretically influence the rate of insertion and thus that of trapping 
events, is the accessibility of the chromatin of the genomic region. For this reason, gene 
which are involved in transcriptional pathways, for example, could be reached more 
easily by DNA vectors used for mutagenesis. These regions are considered “gene 
trapping hot spots”. These regions have been observed before but have never been 
investigated in further detail (Hansen et al., 2003). The distribution of these regions 
across the genome appears to be random and uniform. Another factor that could influence 
the rate of gene trapping is the overall size of the gene locus because the more space is 
available for insertion of the vector, the more likely the event is to occur. Thus we ranked 
genes and trapclusters according to the number of trapping events and normalized the 
dataset for overall locus size in order to identify genes that are likely to be trapped at high 
rates due to their expression levels. In this manner we selected 383 genes which we 
defined as being “hypertrapped”. The first 50 genes are shown in Table 3. This number 
represents less than 5% of all the genes trapped but contains more than 20% of all gene 
traps sequenced. 
To test if hypertrapped genes indicate genes that are highly expressed in ES cells, 
we performed a real-time PCR experiment. We chose 10 genes form the hypertrapped 
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gene list and, as a control, we also chose randomly 10 genes that were trapped once (the 
median rate of trapping). Moreover we compared the expression levels obtained for these 
genes in ES cells to the Oct4 gene, a well known marker of these cells (Niwa et al., 
2000). The results show that 80% of the hypertrapped genes we tested were expressed at 
levels significantly higher than the control set and also that these levels of expression 
were comparable to those of Oct4 (Fig. 14). These data confirmed that this set of genes is 
significantly expressed in ES cells at levels similar to those of a gene which is known to 
play an important role in these cells. A comparison with other previously published 
datasets of expression profiling in ES cells revealed remarkably low overlap. Among the 
genes tested, only one, Scpep1, is present in two of three previously published data sets. 
This is a serine carboxilpeptidase which takes part in the activation of other proteins after 
a proteolitic cut. Immunohistochemical studies on this protein showed that Scpep1, while 
in the embryo, is expressed in the heart, vascular apparatus and the aortic skeletal muscle, 
while in the adult it is expressed in endothelial cells (Lee et al., 2006). 
Another hypertrapped gene is Mshi2h (Musashi homolog 2). It has been shown 
recently that this gene is involved in the maintenance of ES cell identity (Siddal et al., 
2006) although it is not found to be significantly expressed in expression profiling studies 
published until now. Other hypertrapped genes all appear to be involved in early 
development. They include: Erdr1 (erythroid differentiation regulator 1), which is known 
to be higly expressed in the early phases of erythroid lineage development and in cephalic 
mesenchyme development, just like klf9 (Krueppel like factor 9) (Martin et al., 2001); 
Gabarapl2 (GABA receptor associated protein like 2) is highly expressed in the early 
developmental stages of the neural tube and the notochord (Liang et al., 2004); Rbpms 
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(RNA-binding protein with multiple splicing) is involved in heart development (Gerber et 
al., 1999) and Cfdp1 (Craniofacial development protein 1) in craniofacial development 
(Mukhopadhyay et al., 2006). Other hypertrapped genes are involved in chromatin 
remodeling, such as Cbx5 (Chromobx protein homolog 5) (Yamaguchi et al., 1998), in 
protein folding, such as Pfdn1 (prefoldin 1) (Zako et al., 2005) or in ubiquitination 
pathways, such as Ube2r2 (ubiquitin-conjugating enzyme E2R2) (Semplici et al., 2002). 
These results suggest that hypertrapped genes constitute a novel set of genes that 
are expressed at significant levels in ES cells and might be relevant to clarify further 
mechanisms that characterize these cells.  
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Verification of shuffled conserved elements in the vertebrate lineage 
 
In the second part of this work we investigated in vivo the function of shuffled 
conserved non-coding elements. These elements, conserved across the vertebrates, were 
identified using a combination of different tools. Firstly, orthologous loci from four 
mammalian genomes were used to identify “rCNEs”, i.e. regionally-conserved elements. 
Subsequently, these rCNEs were compared with orthologous loci in fishes to investigate 
if the conservation was also extended in these organisms. In this way, we identified 
shuffled conserved elements (SCEs), i.e. regions of the mouse genome conserved in the 
Takifugu rubripes orthologous locus with 40bp length and 60% conservation. Thus 
21,427 non-redundant, non-genic, shuffled conserved elements were found in 30% of the 
genes analyzed (2,911). Only 28% mantained the same orientation and the same position 
with respect to the gene and were name “collinear”, while the remaining SCEs were 
shuffled, i.e. have either changed orientation or position or both between the mouse and 
fugu genome during the evolutionary time separating these two organisms (Fig. 15). We 
further proved that the extent of shuffling observed was not due to an assembly artifact 
by verifying the collinearity independently in two fish genomes (Fugu and Tetraodon). 
Moreover we showed that conserved elements are significantly more often collinear in 
the 500bp window adjacent to the TSS of the gene as compared to any other analyzed 
region, probably owing to elements which are position and orientation constrained in the 
core promoter region.  
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Verifying SCE function 
To investigate a putative function for the SCEs identified, we performed an 
overlap analysis with 98 known mouse enhancer elements annotated in Genbank. The 
overlap of SCEs was compared with the overlap of two other datasets of conserved non-
coding sequences which show conservation in fishes. Interestingly, we showed that the 
SCEs dataset overlapped with 18 known enhancers while the CNE and UCE datasets 
overlapped with only 1 and 2 known enhancers respectively. 
To corroborate these findings and validate the enhancer activity of these SCEs, 
we screened these elements in zebrafish embryos. Thus, DNA fragments amplified from 
the  fugu genome were purified and than co-injected using a construct containing the shh 
(sonic hedgehog) promoter and LacZ as a reporter gene. The co-injection was performed 
into zebrafish embryos at the early stages of development (1-2 cell stage) and after 24 hrs 
of development LacZ expression was observed. We counted about 60 embryos for each 
injected DNA fragment. We tested 27 fragments, 4 of which overlapping with known 
mouse enhancers that have never been tested in fish before. The remaining 23 did not 
overlap to any known feature.  
We also injected, as a control, 12 non-coding, non-repeated and non-conserved 
fragments, 9 of them were from the same genes from which SCEs have been chosen 
while the remaining 3 were from random genes. As previously reported, this type of 
analysis is characterized by significant mosaicism of the expression of the transgene 
(Westerfield et al., 1992). To obtain an expression profile of the enhancer activity, we 
counted the number of cells stained for X-gal and we annotated the position of the 
expressing cells from a large number of embryos on expression maps. Expression maps 
represent a composite overview of the LacZ positive cells of all embryos tested. We 
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found that, when compared to the embryos injected with only the hsp lacZ construct, 22 
out of the 27 fragments tested showed a clear enhancer activity, 3 fragments out of the 4 
known mouse enhancers conserved in fish also act as enhancers in fish. Interestingly, we 
observed that the enhancer effect for each of the fragments tested was tissue specific, not 
generalized.  
We also examined expression data from the Zebrafish Information Network 
(ZFIN) to compare the results obtained with the expression pattern of the genes 
neighboring the elements tested. Interestingly, several SCEs belonging to a single gene 
locus showed similar tissue specific activity. For example, we tested 4 different 
fragments belonging to the ets1 locus. For all these fragments we observed a high 
specificity for blood precursors (see Fig. 16, SCE 1646). This finding corresponds with 
previously reported data which show that ets1 is expressed in the venous and artherial 
system. Moreover, both fragments tested from the zfmpm2 locus (fog2, Walton et al., 
2006) showed specific enhancer activity in the CNS, in line with the expression of both 
fog2 paralogs that is brain specific (Walton et al., 2006). The fragment tested for the mab-
21-like genes had specific enhancer activity in the CNS and in the eye (SCE 4939). This 
expression mirrors the pattern previously observed in the brain, eye and neurons (Kudoh 
et al., 2001; Kudoh et al., 2001b). SCEs from pax6 and hmx3 genes showed enhancement 
specific to the CNS, which also corresponds to previously reported expression patterns 
for these genes (Sprague et al., 2003). An SCE located in the jag1b locus showed specific 
expression in the CNS and in the eye. This result is only partially in line with the reported 
expression of this gene, which is reported to be expressed in the rostral end of the 
pronephric duct, nephron primordia, and in the region extending from the optic vesicle to 
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the eye (Zecchin et al., 2005). Moreover, we identified novel enhancer activity for the 
SCEs neighbouring lmx1b1, which showed CNS specificity, and SCEs found within 
mapkap1, tmeff2 and 3110004L20Rik (producing integral membrane protein) and elmo1 
(associated with cytoskeleton), which showed strong generalized or tissue specific 
activity. For these genes there was no comparable expression data. In contrast only 2 of 
12 (about 17%) of the control elements showed significant enhancement of LacZ activity 
(Table 4). 
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Figure 9. Prediction of novel exons (1172) identified on RefSeq genes.  
The hypotetical exons are primarly external exons (785), as well as 5’ exons (260) and 3’ 
exons (127). 
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Table 1. Verification of 40 novel exons tested by RT-PCR using RNA extract from 
ES cells, whole E14.5 embryo, heart, brain and eye.  
The table indicates exons which were found only in ES cell RNA as “ES only”, those that 
were absent in ES cell RNA but present in all other tissue as “ES-absent”, those that were 
detected in all RNAs tested as “ubiquitous”, those that showed complex on / off patterns 
and different products in the RNAs tested as “complex”, and those that could not be 
detected in any of the RNAs tested as “absent”. 
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Figure 10. Discovery of novel exons on known RefSeq genes. 
The figure shows six samples of RefSeq genes to which were added novel exons using 
gene trap data, as well as images of the RT-PCR results in several tissue RNA and in ES 
cells RNA. 
QuickTime™ and a
TIFF (LZW) decompressor
are needed to see this picture.
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Figure 11. Prediction of 1,997 novel genes and 6,423 novel transcripts found within 
known gene loci.  
1,333 novel genes are nested while 792 putative antisense. 
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Table 2. Results of RT-PCR verifications on ES cell RNA of 50 novel transcripts 
predicted to exist on the basis of gene trap sequence tags.  
The table separates genes that were confirmed from those that were not confirmed. 
Moreover it separates transcripts that were found nested within known genes, antisense 
on known genes, as well other strand alone transcripts shown as novel. 
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Figure 12. Discovery of novel genes based on trapclusters. 
Schematic representation of six samples of novel multi exon genes predicted using gene 
trap data and available CpG islands and Eponine transcription start site annotation, 
verified by RT-PCR on ES cell RNA. 
QuickTime™ and a
TIFF (LZW) decompressor
are needed to see this picture.
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Figure 13. In situ hybridization of trapcluster gene TCLG1417 on E14.5 mouse. 
This gene shows an highly specific signal within the III (C) and IV (D) ventricle of the 
choroids plexus, and in the eye (E, F) in the inner ear (cochlea G, H). 
 
Known gene Trap-Cluter Gene RT-PCR verified 
 
Eponine-TSS 
 
Cpg islands 
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Table 3. List of the first 50 hypertrapped genes.  
For each gene it has been reported the identificative RefSeq, name, genomic localization, 
description, number of gene trapping experiments. 
Refseq_ID Gene Genomic localization Description Trap (n)
NM_133362 Erdr1 ChrNT_051172:6351-7878 (-) erythroid differentiation regulator 1 707
NM_054043 Msi2h Chr11:88067453-88539178 (-) Musashi homolog 2 (Drosophila) 419
NM_026027 Pfdn1 Chr18:36627482-36678298 (-) prefoldin 1 323
NM_011801 Cfdp1 Chr8:111066063-111151900 (-) craniofacial development protein 1 270
NM_008850 Pitpna Chr11:75313766-75354436 (+) phosphatidylinositol transfer protein, 
alpha 
404
NM_007626 Cbx5 Chr15:103258715-103303122 (-) chromobox homolog 5 (Drosophila 
HP1a) 
446
NP_062707 Rbpms Chr8:32588246-32735409 (-) RNA binding protein gene with 
multiple splicing 
449
NM_010638 Klf9 Chr19:22379148-22404833 (+) Kruppel-like factor 9 162
NM_029023 Scpep1 Chr11:88745108-88776520 (-) serine carboxypeptidase 1 203
NM_026275 Ube2r2 Chr4:41274873-41332222 (+) ubiquitin-conjugating enzyme E2R 2 150
NM_026693 Gabarapl2 Chr8:111238427-111253087 (+) gamma-aminobutyric acid (GABA-A) 
receptor-associated protein-like 2 
224
NM_033327 Zfp423 Chr8:86945303-87244633 (-) zinc finger protein 423 239
NM_194059 Nanos3 Chr8:83436801-83439620 (-) nanos homolog 3 (Drosophila) 286
NM_009980 Ctbp2 Chr7:127353899-127489680 (-) C-terminal binding protein 2 189
NM_013482 Btk ChrX:128087275-128128084 (-) Bruton agammaglobulinemia tyrosine 
kinase 
431
NM_018810 Mkrn1 Chr6:39533207-39555818 (-) makorin, ring finger protein, 1 164
NM_026391 Ppp2r2d Chr7:133232602-133269297 (+) protein phosphatase 2, regulatory 
subunit B, delta isoform 
171
NM_007632 Ccnd3 Chr17:45023592-45118144 (+) cyclin D3 216
NM_025927 Mrpl45 Chr11:97136944-97151008 (+) mitochondrial ribosomal protein L45 145
NM_008034 Folr1 Chr7:95964456-95976886 (-) folate receptor 1 (adult) 164
NP_035727 Tjp2 Chr19:23332680-23378444 (-) tight junction protein 2 266
NM_145510 Rabif Chr1:134344924-134358149 (+) RAB interacting factor 135
NM_198417 C030039L03RikChr7:23067546-23081244 (+) RIKEN cDNA C030039L03 gene 
(C030039L03Rik), mRNA 
64
NM_013625 Pafah1b1 Chr11:74399611-74450329 (-) platelet-activating factor 
acetylhydrolase, isoform 1b, beta1 
160
NM_009456 Ube2l3 Chr16:15923030-15972516 (-) ubiquitin-conjugating enzyme E2L 3 255
NM_001003918 Usp7 Chr16:8364074-8464206 (-) ubiquitin specific protease 7 299
NM_023197 2310008H09RikChr7:112719648-112732117 (-) RIKEN cDNA 2310008H09 gene 
(2310008H09Rik), mRNA 
149
NM_145823 Pitpnc1 Chr11:107032524-107158727 (-) phosphatidylinositol transfer protein, 
cytoplasmic 1 
226
NM_026615 2900073H19RikChr2:29759552-29777159 (+) RIKEN cDNA 2900073H19 gene 
(2900073H19Rik), mRNA 
128
NM_027230 Prkcbp1 Chr2:165242023-165353684 (-) protein kinase C binding protein 1 351
NM_016786 Hip2 Chr5:64339101-64400758 (+) huntingtin interacting protein 2 121
NM_183278 2200001I15RikChr14:32488464-32491975 (-) RIKEN cDNA 2200001I15 gene 
(2200001I15Rik), mRNA 
151
NM_008692 Nfyc Chr4:119779884-119848112 (-) nuclear transcription factor-Y gamma 197
NP_031523 Atf1 Chr15:100285518-100317872 (+) activating transcription factor 1 185
NM_026532 Nutf2 Chr8:105156480-105176250 (+) nuclear transport factor 2 96
NM_008942 Npepps Chr11:97028021-97101651 (-) aminopeptidase puromycin sensitive 158
NM_009642 Agtrap Chr4:146569424-146580366 (-) angiotensin II, type I receptor-
associated protein 
102
NM_007792 Csrp2 Chr10:110543028-110562471 (+) cysteine and glycine-rich protein 2 113
NM_175294 8430423A01RikChr1:131762352-131784791 (+) Nuclear ubiquitous casein and cyclin-
dependent kinases substrate (JC7). 
99
NM_144787 Jmjd2c Chr4:73303717-73467081 (+) jumonji domain containing 2C 185
NM_016802 Rhoa Chr9:108375967-108407598 (+) ras homolog gene family, member A 97
NM_148934 Gtrgeo22 Chr10:79791798-79798648 (+) gene trap ROSA b-geo 22 94
NM_009864 Cdh1 Chr8:105899006-105965884 (+) cadherin 1 190
NM_008602 Miz1 Chr18:77186924-77275519 (+) Msx-interacting-zinc finger 143
NM_013827 Mtf2 Chr5:107136124-107178719 (+) metal response element binding 
transcription factor 2 
223
NM_013512 Epb4.1l4a Chr18:34019351-34229942 (-) erythrocyte protein band 4.1-like 4a 179
NM_145441 Ubxd4 Chr12:4054764-4083225 (-) UBX domain containing 4 133
NM_020600 Rps14 Chr18:60999976-61003871 (+) ribosomal protein S14 82
NM_172860 Cbfa2t2h Chr2:153893456-153996294 (+) core-binding factor, runt domain, alpha 
subunit 2, translocated to, 2 homolog 
(human) 
127
NM_021878 Jarid2 Chr13:44305483-44495794 (+) jumonji, AT rich interactive domain 2 146
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Figure 14. Real-time RT-PCR verification of level of expression of hypertrapped 
genes. 
The bar chart shows the levels of expressions of 10 hypertrapped genes (in red) and 10 
genes trapped 1 or 2 times. 80% of hypertrapped genes are expressed at significantly 
higher levels than genes trapped at the median rate of 1 trap per gene. 
QuickTime™ and a
TIFF (LZW) decompressor
are needed to see this picture.
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Figure 15. Shuffling categories of SCEs. 
SCEs are categorized basing on their change in location and orientation in Fugu 
rubiprens with respect to their location and orientation in mouse locus. A) Collinear 
SCEs: elements that have not undergone any change in location or orientation within the 
entire gene locus. B) Reversed SCEs: elements that have changed their orientation in the 
fish locus with respect to the mouse locus, but have remained in the same portion of the 
locus. C) Moved SCEs: elements that have moved between the pre-gene, post-gene and 
intronic portion of the locus. D) Moved-reversed SCEs: elements that have undergone 
both of the above changes. 
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Figure 16. Expression profiles of X-Gal stained embryos. 
A/B/C/D/E/F. Expression profiles of 1 day old X-Gal stained zebrafish embryos. Each 
expression map represents a composite overview of the LacZ positive cells of 65-175 
embryos. Gene names and fragment/SCE are shown. 
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Table 4. Analysis of X-Gal staining in zebrafish embryos co-injected with the Hsp 
promoter and SCEs or control fragments. 
For each DNA fragment tested the following information is given: from left to right: the 
gene locus in which the DNA fragment is found, the size of the SCE, summary about the 
potentially enhancer function of the element (Y=yes, N=not), the number of embryos 
injected, the p-value indicating the significance of the number of cells observed in the 
frangment tested versus the LacZ: Hsp control for each tissue. 
gene name
SCE 
length 
(bp)
Enhancer
n. of 
embryos
cells muscle
notochor
d
CNS eye ear vessels other
no lacZ neg 161 40 p-value p-value p-value p-value p-value p-value p-value
Shh ArC pos 96 242 8.48E-07
Shh 12058 45 y 139 69 6.86E-09
Otx2 13988 51 y 111 93 0.6444 0.006269 0.5536 0.3155
Gata3 15402 40 y 107 103 0.398 0.5764 0.1906 1
Ets 8744 40 y 105 180 0.002593
4.78E-
09
Ets 8745 46 Y 133 210 0.1558 0.6015 0.3619
2.15E-
06
Ets 8726 41 Y 159 345 0.05534 0.6131 0.1485
2.08E-
06
Ets 8728 48 Y 149 176 0.0444 0.129
0.0792
4
1.31E-
05
Pax2b 31027 39 Y 149 105 0.002374 0.06327 0.1902
Pax6a 15696 33 Y 133 122 8.21E-06 0.3343
0.0126
8
Pax3 24781 42 N 124 67 0.02982 0.5287 1
Zfpm2 23818 48 Y 140 119 1.49E-06 0.01296 1
Zfpm2 23838 48 Y 131 148
0.000357
6
0.04369 0.1231
Tmeff2 26014 48 N 164 125 0.7654 0..2301 0.3371 0.2801
Tmeff2 26015 38 Y 120 159 0.001035 0.303 0.2088
Tmeff2 26016 51 Y 109 148
0.000630
9
0.0149 0.5862
Jag1b 16407 37 N 136 98 1 0.1849 1 1
Jag1b 16408 55 Y 142 109 5.45E-08 0.006524 0.3245
Jag1b 16409 44 N 106 54 1 0.5088 1 0.5058
Mapkap1 17058 37 Y 143 295 0.6825 0.05292 0.3788 0.6065 1
Mapkap1 17059 42 Y 136 171 0.6686 0.004037 0.5973 0.077 0.5197
Mab211
2
23001 39 Y 142 317 1.24E-07 0.004985 0.2339
Mab211
2
23002 37 Y 155 122 7.85E-08 0.004138
Hmx3 11669 150 Y 165 136 0.001029 0.07062
0.0142
3
Lmx1b 17027 300 Y 116 105 0.00762 0.1876 1
3110004
L
5803 45 N 65 16 0.2929 1
3110004
L
5802 39 Y 122 320 0.1874 0.01209
Elmo1 6026 45 Y 103 76 0.007132 0.6848
Ets 11216 N 104 74 1 0.6954
Gata3 3255 N 174 110 0.04481 0.281 0.5739
0.0216
3
1300007
F
2797 N 157 115
Tmeff2 198 N 145 23 0.7448 0.6597 0.3651
Mab211
2
909 N 165 92 0.06359 1 1 1
3110004
L
410 N 107 23 0,0198
Elmo1 10157 N 146 38 0.287 0.8126
Shh 11271 N 165 83 3.34E-07 1 1 1
Impact 5990 N 150 101 0.6496 0.2754 0.0622
Ubl7 268 N 117 644
0.000332
5
7.15E-11 0,02555 0.6197
Lmx1b 11767 Y 116 15 0.2743 0.0707 1
Irx3 5945 N 93 15 0.03938
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DISCUSSION 
 
It might surprising that about six years after the first draft of the human genome (Venter 
et al., 2001; Lander et al., 2001) and three years after the announcement of the 
completion of the genome sequence (International Human Genome Sequencing 
Consortium, 2004) we still do not have a complete set of all the genes that are encoded by 
the human genome. This is due to the ease with which sequence data is collected, and the 
difficulty in obtaining functional data in a similarly high throughput manner. It is for this 
reason that the functional characterization of every single gene within the mammalian 
genome is one of the major aims of the post-genomic era. Thus, in recent years, the 
interest in tools that enable genome-wide mutagenesis in a streamlined manner has 
increased significantly.  
Among the available approaches used to identify and characterize novel genes, 
gene trapping in mouse ES cells has emerged as a powerful tool which enables analysis 
of mammalian gene function in a post-genomic era. The application of this technique in a 
genome-wide manner should allow the identification of most, if not all, active transcripts 
in the genome of ES cells and thus it was chosen as an innovative tool for genome 
annotation.  
In our study, starting with a large data set of all available sequences derived from 
gene trapping experiments we investigated if they allowed us to decipher the ES cell 
transcriptome, as well as the mouse genome at a wider level. Notably, we found that 38% 
of trapclusters cannot be mapped to genomic regions previously annotated by other 
existing databases such as RefSeq, Ensembl, Fantom or Unigene (Fig. 17). 
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Moreover, we observed a richness in alternative splicing for 5’ and 3’ exons. 
Interestingly, using gene trapping, we refine the structure of existing known genes adding 
novel exons. The reason why we added a larger number of internal exons with respect to 
external ones may depend on the fact that this technique usually provides sequences from 
integration events which occur within introns. By RT-PCR experiments we were able to 
validate that 70% of these candidate exons are really expressed, and that often they 
exhibit a tissue specific pattern of expression. The identification of new exons on genes 
coming from a well-annotated database such as RefSeq stresses the incomplete 
annotation of these genes. These findings are in line with the fact that even though only a 
small portion of human genes is known to be lacking from computational predictions, the 
exact genomic structure of these genes seems to be correct only for approximately 50% 
of them.  
 We demonstrated with our findings that 40% of the exons that were added can be 
detected in ES cells, while a further 30% are expressed in a tissue specific manner and 
are not detectable in ES cells as was verified by testing four additional RNA sources. 
Thus it is reasonable hypothesize that a higher proportion of our novel exons could be 
verified if we investigated more developmental stages and tissues. Moreover, these 
results suggest that genes which are successfully trapped in ES cells are often expressed 
at very low levels in these cells, while in other tissues they could be expressed at higher 
levels thus, showing a specific pattern linked to specific tissues, stages and cell types 
upon differentiation.  
The fact that gene trapping in ES cells could reveal a higher number of novel genes 
than it had been shown before using cDNA and EST based approaches is probably due to 
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the different levels of expression. Probably these genes are expressed at high levels at 
specific time points and in cell types (such as ES cells) that have not been used to 
produce libraries for EST collection.  
RT-PCR, real-time PCR, in situ hybridization, as well as computational approaches 
(multispecies alignments, comparison with tiling array data) were employed to 
demonstrate that the 65% of our trapclusters correspond to novel genes which are truly 
expressed in ES cells. Particularly, the specific expression profile showed by in situ 
hybridization on the TCLG1417 predicted gene within the auditory pathway was 
interesting taking into consideration that it is a novel non-coding gene that does not fall in 
the much studied microRNA category.  
It is well known that ES cells express a wide number of genes at basal level and a 
few hundreds genes at high levels (Sharov et al., 2003). One can therefore assume that 
highly expressed genes might be easier to identify using gene trapping techniques. 
Several studies indicated that the genome presents specific regions that are hot spots for 
this technique. In our work we demonstrated by real time PCR experiments that these 
hotspot regions correspond to genes which are significantly expressed in ES cells and that 
their expression levels are comparable to Oct4 gene, a well known ES cell marker. 
Hypertrapped and trapped categories both contain genes that are related to basic 
molecular functions of the cell, such as transcription, translation and degradation of 
proteins. Hypertrapped genes show a balanced subselection of the same types of genes. 
Interestingly the latter dataset includes some factors that are involved in the early stages 
of development such as Erdr1, Klf9, Gabarapl2, Rbpms, Cfdp1. These factors might be 
highly expressed in pluripotent cells to be “ready to go” once these cells differentiate into 
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a specific fate (i.e. cell type). It could be hypothesized that their expression might be 
under the control of transcription factors which are known to guarantee the maintenance 
of pluripotency in the germinal cell, such as for example Oct4, Nanog, Sox2 and STAT3. 
A comparative analysis of hypertrapped genes against already known sets of genes 
involved in the “stemness profile”, derived from expression profiling experiments (Vogel 
et al., 2003) showed a remarkably low overlap. In particular it is striking that genes 
belonging to our set of hypertrapped genes, which are expressed at significantly higher 
levels than “normally trapped” genes (as demonstrated by real-time PCR) are not present 
in the datasets published. This result, together with that obtained on Oct4, suggests that 
hypertrapped genes might identify a set of genes whose expression is tightly controlled, 
as it is for Oct4, and which could thus be difficult to identify by expression profiling, 
while playing an important role in the biology of these cells. 
Our data taken together indicates clearly that gene trapping in ES cells holds high 
value for biology and that its utility extends far beyond its use as a mere mutagenesis 
tool. We demonstrated that thousands of novel genes and transcripts exist which had 
never been annotated; thus we can conclude that gene-trap mutagenesis is an efficient 
approach for annotating and dissecting the function of mammalian genes. 
Another fascinating challenge of the post genomic era is that of understanding the 
intricate processes of gene regulation in vertebrates. Comparative genomics is one of the 
approaches commonly used to identify non-coding regions of the genome which are 
conserved across evolution and which might play a role in the process of gene regulation. 
In order to define novel putative regulatory elements in the vertebrate genome we 
focused our attention on the conservation of non-coding elements between fish and 
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mammalian genomes. We hypothesized that over such long evolutionary distances, over 
which entire genes are known to shuffle, non-coding elements should shuffle at even 
greater extent given that their function is often position and orientation indipendent. Thus 
we developed a pipeline using the CHAOS algorithm for detecting conserved elements 
which could have shuffled across evolution and we then proceeded to test a subset of 
them (as well as a set of matched negative controls) using an enhancer assay in zebrafish 
to investigate their functionality.  
Using a restricted set of candidate non-coding regulatory sequences identified by 
comparative analysis we were able to demonstrate their cis-acting regulatory activity in 
transgenic zebrafish. We demonstrated by co-injection the enhancer activity of the 
majority (80%) of the elements identified. We followed the expression profile of each 
fragment in 24hrs old co-injected embryos. As a positive control ArC expression was 
verified in the notochord as previously reported. The fact that these elements are well 
conserved in Fugu, demonstrates that the expression regulation of expression of genes 
involved in development is conserved. The transient expression of these elements in 
zebrafish showed an interesting tissue specific pattern for most of them, and where the 
pattern of the neighbouring gene was known the pattern produced by the patter was often 
similar. Notably, our data demonstrated that 80% of the elements tested do enhance 
transcription in vivo as compared to a single element in the control set of fragments, and 
that most drive tissue specific expression of a minimal promoter.  
Taken together our data demonstrates that the combination of a comparative 
genomics approach and functional screening is able to produce a large data set that will 
be useful for further investigation helping to expand the understanding of the genome and 
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understanding the intricate mechanisms of gene regulation, taking into account novel and 
as yet not very well understood players such as those hiding in the non-coding realms of 
the genome. 
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Figure 17. Annotation of Trap Clusters. 
Pie chart showing the annotation of genomic regions mapped by trapclusters, indicating 
that 38% of the trapclusters analyzed cannot be mapped to regions of the genome which 
have already been annotated with gene structures by RefSeq, Ensembl, Fantom or 
UniGene. 
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APPENDIX: PRIMERS USED  
 
Primers used to amplify novel 
transcripts  
forward_name forward_seq 
FP81.1.2 GAGCCCTGCTGTGGGTGAAGAACT 
FP81.1.2 GAGCCCTGCTGTGGGTGAAGAACT 
FP81.2.2 TTGTTCCAGAAGGAGGCACAGTCC 
FP330.1.1 CACGTCACATCACTGCTCCCAACT 
FP330.1.1 CACGTCACATCACTGCTCCCAACT 
FP330.2.2 GAGGGGTTCTTGCCTGTTTGTGTG 
FP330.2.2 GAGGGGTTCTTGCCTGTTTGTGTG 
FP400.1.2 TGGGAAGTTGAGCAGGAAACTCCA 
FP400.1.2 TGGGAAGTTGAGCAGGAAACTCCA 
FP400.2.2 GTCCTGGTCCCAAGACCTCAGCTT 
FP400.2.2 GTCCTGGTCCCAAGACCTCAGCTT 
FP455.1.2 GCCTACTGCCTCGTTCCCAGTTTC 
FP455.1.2 GCCTACTGCCTCGTTCCCAGTTTC 
FP455.2.4 AGCCCAGAGAGACAGACCGACAAG 
FP467.1.1 TTGCTGCGGAGTGTCTCTGAATTG 
FP467.1.1 TTGCTGCGGAGTGTCTCTGAATTG 
FP467.1.1 TTGCTGCGGAGTGTCTCTGAATTG 
FP467.2.1 ATTTGAAGCTGCCCCTCAAAGGAA 
FP467.2.1 ATTTGAAGCTGCCCCTCAAAGGAA 
FP467.2.1 ATTTGAAGCTGCCCCTCAAAGGAA 
FP467.3.1 CCCTAGTTGCCCAGAAATTGCAGA 
FP467.3.1 CCCTAGTTGCCCAGAAATTGCAGA 
FP486.1.2 TCAGGGCATGGAGCAAATCTTCTG 
FP486.1.2 TCAGGGCATGGAGCAAATCTTCTG 
FP486.1.2 TCAGGGCATGGAGCAAATCTTCTG 
FP486.2.2 TTCGTGCTTGAGATGCAGAGGGTA 
FP486.2.2 TTCGTGCTTGAGATGCAGAGGGTA 
FP486.2.2 TTCGTGCTTGAGATGCAGAGGGTA 
FP486.3.2 CCCATGTCTTGTGGGGACAAAGAG 
FP486.3.2 CCCATGTCTTGTGGGGACAAAGAG 
FP724.1.1 CCTCTCGGAAAAAGGGTCAACTGG 
FP724.1.1 CCTCTCGGAAAAAGGGTCAACTGG 
FP724.2.2 CAGCCTGCTAGGATGCCTCTGTTG 
FP724.2.2 CAGCCTGCTAGGATGCCTCTGTTG 
FP757.1.3 ATCCCTGAGGAGCTGACGGTGAAC 
FP757.1.3 ATCCCTGAGGAGCTGACGGTGAAC 
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FP757.2.3 GTGCTTTGTTTCGCAGGCATTTTC 
FP757.2.3 GTGCTTTGTTTCGCAGGCATTTTC 
FP869.1.1 AGCCAGCTTCTCTCACCACTTGGA 
FP869.1.1 AGCCAGCTTCTCTCACCACTTGGA 
FP869.2.2 ACCGTGGATGAGGAGATCGATGAA 
FP947.1.2 CCCTAAGCGAACCTTGGAGAATGC 
FP947.1.2 CCCTAAGCGAACCTTGGAGAATGC 
FP947.2.3 CCATTGAGCCACCATCCACATACA 
FP947.2.3 CCATTGAGCCACCATCCACATACA 
FP978.1.3 AAGGAGAAAGCCCACTTCCTCGAA 
FP978.1.3 AAGGAGAAAGCCCACTTCCTCGAA 
FP978.2.2 ACAGCCTGGGAAAATGGAGATGCT 
FP1004.1.3 GGAGCCGGTGACACTGAATAGCAC 
FP1004.1.3 GGAGCCGGTGACACTGAATAGCAC 
FP1004.1.3 GGAGCCGGTGACACTGAATAGCAC 
FP1004.2.2 GCACAAGGGTGGCTGATTCAAGAC 
FP1004.2.2 GCACAAGGGTGGCTGATTCAAGAC 
FP1004.2.2 GCACAAGGGTGGCTGATTCAAGAC 
FP1004.3.1 CCTCACCATATCGGCCCTTTCCTA 
FP1004.3.1 CCTCACCATATCGGCCCTTTCCTA 
FP1004.3.1 CCTCACCATATCGGCCCTTTCCTA 
FP1113.1.2 CAGTTGTCTGATGGGGGACTGAGA 
FP1113.1.2 CAGTTGTCTGATGGGGGACTGAGA 
FP1113.1.2 CAGTTGTCTGATGGGGGACTGAGA 
FP1113.2.1 TGCTGTTAACTAATGGGCCCTCCA 
FP1113.2.1 TGCTGTTAACTAATGGGCCCTCCA 
FP1113.2.1 TGCTGTTAACTAATGGGCCCTCCA 
FP1113.3.1 ATATGGCTGCTCCACTTCCCCAGT 
FP1113.3.1 ATATGGCTGCTCCACTTCCCCAGT 
FP1131.1.1 TGAGGCAATTCAGGGGAGAAAACA 
FP1131.1.1 TGAGGCAATTCAGGGGAGAAAACA 
FP1131.2.2 CACCCCTCCCAGCCTTAGAGAAGA 
FP1153.1.1 ACGGAAACTGGCATCTGCAAGAAA 
FP1153.1.1 ACGGAAACTGGCATCTGCAAGAAA 
FP1153.2.3 GAACAAGCCAAAACCCTGGGAGAG 
FP1153.2.3 GAACAAGCCAAAACCCTGGGAGAG 
FP1205.1.1 CTTGGGGTGGAGCACGAATGTAAG 
FP1259.1.1 TCCTTGCTACCCCGGATTTCATTC 
FP1259.1.1 TCCTTGCTACCCCGGATTTCATTC 
FP1259.2.1 TGACGTGGGAGAGAATGTGAGTGC 
FP1450.1.4 CGCGATGCTGTTCCTGTGATTCT 
FP1450.1.4 CGCGATGCTGTTCCTGTGATTCT 
FP1450.2.1 GTTTCTCACGAGATGCTGCCCTTC 
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FP1520.1.3 TTCCTGCTCCACATGGTGTTTCTG 
FP1520.1.3 TTCCTGCTCCACATGGTGTTTCTG 
FP1520.2.3 TTGACTCAGGTGAGGGCCTAGGTG 
FP1520.2.3 TTGACTCAGGTGAGGGCCTAGGTG 
FP1541.1.2 GTCATCAGCTTCGTGACTGGGTGA 
FP1541.1.2 GTCATCAGCTTCGTGACTGGGTGA 
FP1541.2.4 GGACCACCAGTGGATTCCCTCTGT 
FP1581.1.5 CGGCTTTGGAAATACGAACTTGGA 
FP1581.1.5 CGGCTTTGGAAATACGAACTTGGA 
FP1581.1.5 CGGCTTTGGAAATACGAACTTGGA 
FP1581.2.2 TGGGTCACATATCTGGGGAGGTGT 
FP1581.2.2 TGGGTCACATATCTGGGGAGGTGT 
FP1581.2.2 TGGGTCACATATCTGGGGAGGTGT 
FP1581.3.1 CCCTTCTGATAGCATCTTCCTCTGA 
FP1581.3.1 CCCTTCTGATAGCATCTTCCTCTGA 
FP1590.1.1 TCAGCTAATGGCATAGGGCTTCCA 
FP1590.1.1 TCAGCTAATGGCATAGGGCTTCCA 
FP1590.2.4 AAAAGCCCGATCACCACAGCTTCT 
FP1647.1.1 AAGGACTCGAACCAGCGAATCCAG 
FP1647.1.1 AAGGACTCGAACCAGCGAATCCAG 
FP1647.1.1 AAGGACTCGAACCAGCGAATCCAG 
FP1647.1.1 AAGGACTCGAACCAGCGAATCCAG 
FP1647.2.1 CACGTCAGTTTGGCTTCATTGTGC 
FP1647.2.1 CACGTCAGTTTGGCTTCATTGTGC 
FP1647.2.1 CACGTCAGTTTGGCTTCATTGTGC 
FP1647.2.1 CACGTCAGTTTGGCTTCATTGTGC 
FP1647.3.5 TTTGGACACCACACAAGGTGATGC 
FP1647.3.5 TTTGGACACCACACAAGGTGATGC 
FP1647.3.5 TTTGGACACCACACAAGGTGATGC 
FP1647.3.5 TTTGGACACCACACAAGGTGATGC 
FP1647.4.4 GGGTCATCTCTTCCAATCCAGTGC 
FP1647.4.4 GGGTCATCTCTTCCAATCCAGTGC 
FP1647.4.4 GGGTCATCTCTTCCAATCCAGTGC 
FP1688.1.1 CACTCAGCTTTCTACGGCCCCTCT 
FP1688.1.1 CACTCAGCTTTCTACGGCCCCTCT 
FP1688.2.1 TGACCAACGGAAGGAGGAACACAT 
FP1753.1.1 TCCGCAGCACTTCCCATCTGTTAT 
FP1753.1.1 TCCGCAGCACTTCCCATCTGTTAT 
FP1753.1.1 TCCGCAGCACTTCCCATCTGTTAT 
FP1753.2.3 TGCCTGTGCAGTCCTTACTCAACG 
FP1753.2.3 TGCCTGTGCAGTCCTTACTCAACG 
FP1753.2.3 TGCCTGTGCAGTCCTTACTCAACG 
FP1753.3.2 AGTGTGCCTTGTGCTGTTGTCCAG 
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FP1753.3.2 AGTGTGCCTTGTGCTGTTGTCCAG 
FP1777.1.2 GCACTGAAAGCCCCTGATTGAAGA 
FP1777.1.2 GCACTGAAAGCCCCTGATTGAAGA 
FP1777.2.2 AAGCCGAGTATTGTGGGTGTGGAA 
FP1928.1.1 GTTCAGGTGAGCCGAGAGCAGTGT 
FP1928.1.1 GTTCAGGTGAGCCGAGAGCAGTGT 
FP1928.2.1 TGGGATGTTGCTTGATGACACCAC 
FP1928.2.1 TGGGATGTTGCTTGATGACACCAC 
FP2005.1.2 CGTGGCTCCCTCTACCAATTCTCC 
FP2005.1.2 CGTGGCTCCCTCTACCAATTCTCC 
FP2005.2.1 AGCCATCCAGTAAGGGTTCCAAGC 
FP2005.2.1 AGCCATCCAGTAAGGGTTCCAAGC 
FP2022.1.2 GACCACAGCCTCCATTCACCATTC 
FP2022.1.2 GACCACAGCCTCCATTCACCATTC 
FP2022.2.1 CTCTCCGAGGCTTTGGGCTACAGT 
FP2033.1.2 GGGACCAAGAACCACAGACCTCCT 
FP2033.1.2 GGGACCAAGAACCACAGACCTCCT 
FP2033.1.2 GGGACCAAGAACCACAGACCTCCT 
FP2033.2.1 GCTGAGGGGAGAAACGCGAAATTA 
FP2033.2.1 GCTGAGGGGAGAAACGCGAAATTA 
FP2033.2.1 GCTGAGGGGAGAAACGCGAAATTA 
FP2033.3.1 AGAAACTGGGCGGTCTGAGTCTCC 
FP2033.3.1 AGAAACTGGGCGGTCTGAGTCTCC 
FP2033.3.1 AGAAACTGGGCGGTCTGAGTCTCC 
FP2034.1.1 TGTGAGCCTCGCCCTGCTAAATAA 
FP2034.1.1 TGTGAGCCTCGCCCTGCTAAATAA 
FP2034.1.1 TGTGAGCCTCGCCCTGCTAAATAA 
FP2034.1.1 TGTGAGCCTCGCCCTGCTAAATAA 
FP2034.2.2 CGCAGATGATGATTGTGGACCTGT 
FP2034.2.2 CGCAGATGATGATTGTGGACCTGT 
FP2034.2.2 CGCAGATGATGATTGTGGACCTGT 
FP2034.2.2 CGCAGATGATGATTGTGGACCTGT 
FP2034.3.1 TACTTGCACACCCAAGTCCAGTGC 
FP2034.3.1 TACTTGCACACCCAAGTCCAGTGC 
FP2034.3.1 TACTTGCACACCCAAGTCCAGTGC 
FP2034.3.1 TACTTGCACACCCAAGTCCAGTGC 
FP2034.4.2 GATTCCGCACTGGCAGAGAACCT 
FP2034.4.2 GATTCCGCACTGGCAGAGAACCT 
FP2034.4.2 GATTCCGCACTGGCAGAGAACCT 
FP2034.4.2 GATTCCGCACTGGCAGAGAACCT 
FP2221.1.1 GGAACAAGAAGATGGTGCGACGAC 
FP2221.1.1 GGAACAAGAAGATGGTGCGACGAC 
FP2221.2.1 AGAATCTCTTCAAGGGCGGAGCAC 
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FP2266.1.2 TCAAGCAATGGATGTGGATTTACCC 
FP2266.1.2 TCAAGCAATGGATGTGGATTTACCC 
FP2266.2.1 CAGACGTGAGCTGTAGCCGGACTT 
FP2266.2.1 CAGACGTGAGCTGTAGCCGGACTT 
FP2356.1.1 CGTGCTGGGAAATGTAGGCGATTA 
FP2356.1.1 CGTGCTGGGAAATGTAGGCGATTA 
FP2356.2.1 TGCTCATTCTGATCGGATGTGTCC 
FP2423.1.2 AAACTCAGAAGTGGGCCCCAAGAA 
FP2423.1.2 AAACTCAGAAGTGGGCCCCAAGAA 
FP2423.1.2 AAACTCAGAAGTGGGCCCCAAGAA 
FP2423.2.3 TGGAACCAGAACAGCAAAGCCAAA 
FP2423.2.3 TGGAACCAGAACAGCAAAGCCAAA 
FP2423.2.3 TGGAACCAGAACAGCAAAGCCAAA 
FP2423.3.2 CTGCGTGCAAAAAGGAGAGTGACA 
FP2423.3.2 CTGCGTGCAAAAAGGAGAGTGACA 
FP2486.1.2 CAGCCTGTGAATGAGGTGGACCAT 
FP2519.1.1 CCGGAGGGTAGGGGGTAATCTCAT 
FP2519.1.1 CCGGAGGGTAGGGGGTAATCTCAT 
FP2519.2.1 CTTGCAGATCAGAACGGACCCTGT 
FP2538.1.3 CATGACATGGTACCTGCCTCTGGA 
FP2538.1.3 CATGACATGGTACCTGCCTCTGGA 
FP2538.1.3 CATGACATGGTACCTGCCTCTGGA 
FP2538.2.3 TGCTGAAAGAATGCACCCTGACAA 
FP2538.2.3 TGCTGAAAGAATGCACCCTGACAA 
FP2538.2.3 TGCTGAAAGAATGCACCCTGACAA 
FP2538.3.2 CATGTCACCACCCAAATGCTTGTC 
FP2538.3.2 CATGTCACCACCCAAATGCTTGTC 
FP2538.3.2 CATGTCACCACCCAAATGCTTGTC 
FP2616.1.1 GCTGACTGCTAACCACCTTCACCA 
FP2616.1.1 GCTGACTGCTAACCACCTTCACCA 
FP2616.2.2 TGAGGCATCATTTTAGGCCACAGG 
FP2660.1.2 GGAGTCCCTGGGGTTAAGAGGACA 
FP2660.1.2 GGAGTCCCTGGGGTTAAGAGGACA 
FP2660.1.2 GGAGTCCCTGGGGTTAAGAGGACA 
FP2660.2.4 TGGATAAAGCTCCGATTCCTGCTG 
FP2660.2.4 TGGATAAAGCTCCGATTCCTGCTG 
FP2660.2.4 TGGATAAAGCTCCGATTCCTGCTG 
FP2660.3.1 ATATCACAAAGCGTGCAGGCCAAG 
FP2660.3.1 ATATCACAAAGCGTGCAGGCCAAG 
FP2808.1.4 TTAAATTCGGGGCCGGTACACTTG 
FP2808.1.4 TTAAATTCGGGGCCGGTACACTTG 
FP2808.2.1 ACCACTTGCACATTGAGGGGAAGA 
FP2810.1.1 CCATGGTGATTGCCCCTAGAAACA 
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FP2810.1.1 CCATGGTGATTGCCCCTAGAAACA 
FP2810.2.1 TGACTGTCAGTGGAACAGCCAACC 
FP2847.1.2 CAGAAGCCACAGGATCCCAGATTG 
FP3471.1.2 TCTGGTGCTGATGAGATGGCTCTG 
FP3471.1.2 TCTGGTGCTGATGAGATGGCTCTG 
FP3471.1.2 TCTGGTGCTGATGAGATGGCTCTG 
FP3471.2.3 ACTGTGCTGGCTGGAAACCACTTC 
FP3471.2.3 ACTGTGCTGGCTGGAAACCACTTC 
FP3471.2.3 ACTGTGCTGGCTGGAAACCACTTC 
FP3471.3.1 TGCTTTGGGTAATGTCCGTTCTGG 
FP3471.3.1 TGCTTTGGGTAATGTCCGTTCTGG 
FP3643.1.2 TCGGCTTCTCACCGTGTTTGACTT 
FP3643.1.2 TCGGCTTCTCACCGTGTTTGACTT 
FP3643.2.3 GAGCACACATCCTCCACAGGACAA 
FP3643.2.3 GAGCACACATCCTCCACAGGACAA 
FP4020.1.1 ATCCAGAGGACCGTGCAACAAAAA 
FP4185.1.2 GACAAGCCGGACATAGGGGAAATC 
FP4400.1.1 TCAGCCTTTGCAGCGGAGAAAGTA 
FP4400.1.1 TCAGCCTTTGCAGCGGAGAAAGTA 
FP4400.2.3 CACTGCGGAGACCACTTCTTGTCC 
FP4470.1.3 GGAGAGTGGAAAGGGCCTTCATGT 
FP4470.1.3 GGAGAGTGGAAAGGGCCTTCATGT 
FP4470.2.2 GCCCTGATTTGAGCCCTTCAGTCT 
FP4845.1.3 GCCATGTGCTTACGCAGACAGGTT 
FP4845.1.3 GCCATGTGCTTACGCAGACAGGTT 
FP4845.2.1 CACAGGCCAACTTCTGCTTTACCG 
RP81.2.2 GGACTGTGCCTCCTTCTGGAACAA 
RP81.3.3 ACTGAGGGCCTTTTTGATGCCAAC 
RP81.3.3 ACTGAGGGCCTTTTTGATGCCAAC 
RP330.3.4 GGCTGTCCTGCTCTACCCGGATTA 
RP330.4.1 TTCATGGTTTTCCTGGCGATCTGT 
RP330.3.4 GGCTGTCCTGCTCTACCCGGATTA 
RP330.4.1 TTCATGGTTTTCCTGGCGATCTGT 
RP400.3.2 AGGCCCTTCCCTTGAGACTCTGTG 
RP400.4.2 CAGTCCTAGCTGAGGATGGGGACA 
RP400.3.2 AGGCCCTTCCCTTGAGACTCTGTG 
RP400.4.2 CAGTCCTAGCTGAGGATGGGGACA 
RP455.2.1 TGTCGGTCTGTCTCTCTGGGCTTC 
RP455.3.1 AGGTGGGCTTTTGTCAAGGATGGT 
RP455.3.1 AGGTGGGCTTTTGTCAAGGATGGT 
RP467.3.5 TTCTGCAATTTCTGGGCAACTAGGG 
RP467.4.2 ATGGCACCAGGTCAATAAGGTTGC 
RP467.5.1 TCCTGGAAATGTGCAGATGGATTG 
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RP467.3.5 TTCTGCAATTTCTGGGCAACTAGGG 
RP467.4.2 ATGGCACCAGGTCAATAAGGTTGC 
RP467.5.1 TCCTGGAAATGTGCAGATGGATTG 
RP467.4.2 ATGGCACCAGGTCAATAAGGTTGC 
RP467.5.1 TCCTGGAAATGTGCAGATGGATTG 
RP486.3.5 CAAGACATGGGGGACAAAGAACGA 
RP486.4.1 CAGCCTCAGCATTTCCTGGTCTGT 
RP486.5.1 CCCTCCCTGAGCTGTTAGGTCCTG 
RP486.3.5 CAAGACATGGGGGACAAAGAACGA 
RP486.4.1 CAGCCTCAGCATTTCCTGGTCTGT 
RP486.5.1 CCCTCCCTGAGCTGTTAGGTCCTG 
RP486.4.1 CAGCCTCAGCATTTCCTGGTCTGT 
RP486.5.1 CCCTCCCTGAGCTGTTAGGTCCTG 
RP724.3.1 CGGGCCATGTCTTACTGTCGATGT 
RP724.4.1 ACCCAGCTTCGTTCTCCTATGCTG 
RP724.3.1 CGGGCCATGTCTTACTGTCGATGT 
RP724.4.1 ACCCAGCTTCGTTCTCCTATGCTG 
RP757.3.1 TGAGCTAGAAGGGACCCATGGACA 
RP757.4.4 CTGGCTTCGCCTTCAGCTTTGTAA 
RP757.3.1 TGAGCTAGAAGGGACCCATGGACA 
RP757.4.4 CTGGCTTCGCCTTCAGCTTTGTAA 
RP869.2.1 TGCGTGTCCCGAGAATAGAAAGGA 
RP869.3.1 AAGGCCTAGGCAGGAAGGCAATTT 
RP869.3.1 AAGGCCTAGGCAGGAAGGCAATTT 
RP947.3.1 CTGTCAGCTCGCAGTTCAAGGTCA 
RP947.4.2 CTGCTTGCCCACTCTATGGTCGTT 
RP947.3.1 CTGTCAGCTCGCAGTTCAAGGTCA 
RP947.4.2 CTGCTTGCCCACTCTATGGTCGTT 
RP978.2.1 AGCATCTCCATTTTCCCAGGCTGT 
RP978.3.3 TGTCACTGCACGTTTACAGCAGCA 
RP978.3.3 TGTCACTGCACGTTTACAGCAGCA 
RP1004.4.1 GGCTTTCCAGATCCAGTGTGAGGA 
RP1004.5.2 TGTAAGCCCCTGAGTTAGGCAGCA 
RP1004.6.3 GTCAAGACTCCCTCCGCCTTAGGA 
RP1004.4.1 GGCTTTCCAGATCCAGTGTGAGGA 
RP1004.5.2 TGTAAGCCCCTGAGTTAGGCAGCA 
RP1004.6.3 GTCAAGACTCCCTCCGCCTTAGGA 
RP1004.4.1 GGCTTTCCAGATCCAGTGTGAGGA 
RP1004.5.2 TGTAAGCCCCTGAGTTAGGCAGCA 
RP1004.6.3 GTCAAGACTCCCTCCGCCTTAGGA 
RP1113.3.2 GCTCAGAGCCCGTTCCTGGTTTAG 
RP1113.4.1 TGTCCGGAAAGGTTTTCTCCTGGT 
RP1113.5.1 AAGACATCACCAGGCAGCATCTCA 
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RP1113.3.2 GCTCAGAGCCCGTTCCTGGTTTAG 
RP1113.4.1 TGTCCGGAAAGGTTTTCTCCTGGT 
RP1113.5.1 AAGACATCACCAGGCAGCATCTCA 
RP1113.4.1 TGTCCGGAAAGGTTTTCTCCTGGT 
RP1113.5.1 AAGACATCACCAGGCAGCATCTCA 
RP1131.2.3 CGAGAATCTGCAGCTGTGTCAGGA 
RP1131.3.1 TTTTTCACCGCTCTGGAAGATGGA 
RP1131.3.1 TTTTTCACCGCTCTGGAAGATGGA 
RP1153.3.2 GCCCGACATTAATCCGCAGTCTTT 
RP1153.4.1 AAACCTTAGGGCCAAGCGGAGACT 
RP1153.3.2 GCCCGACATTAATCCGCAGTCTTT 
RP1153.4.1 AAACCTTAGGGCCAAGCGGAGACT 
RP1205.2.4 CTTGGTCCAGCCATGGCAAACTTA 
RP1259.2.1 GCACTCACATTCTCTCCCACGTCA 
RP1259.3.1 GCAATTCAAAGGAATGACCCAGCTC 
RP1259.3.1 GCAATTCAAAGGAATGACCCAGCTC 
RP1450.2.1 TGAAGGGCAGCATCTCGTGAGAAA 
RP1450.3.1 CTGCCGTTTAAACTGTGCATCGTG 
RP1450.3.1 CTGCCGTTTAAACTGTGCATCGTG 
RP1520.3.2 ACTCTTGGTGGGAGCAGGTGGTTT 
RP1520.4.2 CTGGACACCCAGTGCATGAGGAT 
RP1520.3.2 ACTCTTGGTGGGAGCAGGTGGTTT 
RP1520.4.2 CTGGACACCCAGTGCATGAGGAT 
RP1541.2.1 CACAGAGGGAATCCACTGGTGGTC 
RP1541.3.1 TGTTGTGGCCACTGGCTTGTTAGA 
RP1541.3.1 TGTTGTGGCCACTGGCTTGTTAGA 
RP1581.3.1 GAGGAAGATGCTATCAGAAGGGTTGA 
RP1581.4.1 GGAGGTGCTGTTGAGGTCGTCAGT 
RP1581.5.3 GTCACCAGTCCTATGTCCCCACGA 
RP1581.3.1 GAGGAAGATGCTATCAGAAGGGTTGA 
RP1581.4.1 GGAGGTGCTGTTGAGGTCGTCAGT 
RP1581.5.3 GTCACCAGTCCTATGTCCCCACGA 
RP1581.4.1 GGAGGTGCTGTTGAGGTCGTCAGT 
RP1581.5.3 GTCACCAGTCCTATGTCCCCACGA 
RP1590.2.4 AGAAGCTGTGGTGATCGGGCTTTT 
RP1590.3.1 CTCACTGCACAAACAGCGAGTGGT 
RP1590.3.1 CTCACTGCACAAACAGCGAGTGGT 
RP1647.4.1 AAGCCAAAGACACCAGGGTGTTGA 
RP1647.5.2 CTGTGTGATCCAGGGTGGGTGTCT 
RP1647.6.2 GAATTCCCCGTCTTGACAATGCAC 
RP1647.7.1 AGCACATTAGCAGGTCAACCAGGA 
RP1647.4.1 AAGCCAAAGACACCAGGGTGTTGA 
RP1647.5.2 CTGTGTGATCCAGGGTGGGTGTCT 
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RP1647.6.2 GAATTCCCCGTCTTGACAATGCAC 
RP1647.7.1 AGCACATTAGCAGGTCAACCAGGA 
RP1647.4.1 AAGCCAAAGACACCAGGGTGTTGA 
RP1647.5.2 CTGTGTGATCCAGGGTGGGTGTCT 
RP1647.6.2 GAATTCCCCGTCTTGACAATGCAC 
RP1647.7.1 AGCACATTAGCAGGTCAACCAGGA 
RP1647.5.2 CTGTGTGATCCAGGGTGGGTGTCT 
RP1647.6.2 GAATTCCCCGTCTTGACAATGCAC 
RP1647.7.1 AGCACATTAGCAGGTCAACCAGGA 
RP1688.2.1 GGACATGTGTTCCTCCTTCCGTTG 
RP1688.3.2 GGGTTGGGTCTGGCGTCTAGTTTC 
RP1688.3.2 GGGTTGGGTCTGGCGTCTAGTTTC 
RP1753.3.2 CTGGACAACAGCACAAGGCACACT 
RP1753.4.1 CACGTTTGTGTGCCATTGGAGAAG 
RP1753.5.3 CACGGGGTGAAGAGGAGAGTGTGT 
RP1753.3.2 CTGGACAACAGCACAAGGCACACT 
RP1753.4.1 CACGTTTGTGTGCCATTGGAGAAG 
RP1753.5.3 CACGGGGTGAAGAGGAGAGTGTGT 
RP1753.4.1 CACGTTTGTGTGCCATTGGAGAAG 
RP1753.5.3 CACGGGGTGAAGAGGAGAGTGTGT 
RP1777.2.1 TCCACACCCACAATACTCGGCTTT 
RP1777.3.1 TGATGTCTGGAGGAGTGCCATCAG 
RP1777.3.1 TGATGTCTGGAGGAGTGCCATCAG 
RP1928.3.3 ACTGCGCTTCTCGAGTTTCACACC 
RP1928.4.4 GCTTGAGCTTGCACCAAGTTGCTC 
RP1928.3.3 ACTGCGCTTCTCGAGTTTCACACC 
RP1928.4.4 GCTTGAGCTTGCACCAAGTTGCTC 
RP2005.3.2 TGTGGGCAGTAGGAAAGGCAGAAC 
RP2005.4.2 CCACAGAGGGCTCACGGTAATGAA 
RP2005.3.2 TGTGGGCAGTAGGAAAGGCAGAAC 
RP2005.4.2 CCACAGAGGGCTCACGGTAATGAA 
RP2022.2.1 ACTGTAGCCCAAAGCCTCGGAGAG 
RP2022.3.2 TGTCCGGTTTGATCATTGCTGTGT 
RP2022.3.2 TGTCCGGTTTGATCATTGCTGTGT 
RP2033.4.1 TATTCAGGTGGAGTGCAACGTGGA 
RP2033.5.4 GACCGAGAGACGCTTGGTTGAAGA 
RP2033.6.3 GAGTCCGGAGATGGGAACAACACA 
RP2033.4.1 TATTCAGGTGGAGTGCAACGTGGA 
RP2033.5.4 GACCGAGAGACGCTTGGTTGAAGA 
RP2033.6.3 GAGTCCGGAGATGGGAACAACACA 
RP2033.4.1 TATTCAGGTGGAGTGCAACGTGGA 
RP2033.5.4 GACCGAGAGACGCTTGGTTGAAGA 
RP2033.6.3 GAGTCCGGAGATGGGAACAACACA 
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RP2034.5.2 GGCCAGGTTCCTCTCTGTGCTTCT 
RP2034.6.4 GCAGGGATTTGGAAGGATGTCTGA 
RP2034.7.2 GGTGACCTGAAGATCAGGCAGGAG 
RP2034.8.1 GGGGAAATACAGAGCCCCATCTGA 
RP2034.5.2 GGCCAGGTTCCTCTCTGTGCTTCT 
RP2034.6.4 GCAGGGATTTGGAAGGATGTCTGA 
RP2034.7.2 GGTGACCTGAAGATCAGGCAGGAG 
RP2034.8.1 GGGGAAATACAGAGCCCCATCTGA 
RP2034.5.2 GGCCAGGTTCCTCTCTGTGCTTCT 
RP2034.6.4 GCAGGGATTTGGAAGGATGTCTGA 
RP2034.7.2 GGTGACCTGAAGATCAGGCAGGAG 
RP2034.8.1 GGGGAAATACAGAGCCCCATCTGA 
RP2034.5.2 GGCCAGGTTCCTCTCTGTGCTTCT 
RP2034.6.4 GCAGGGATTTGGAAGGATGTCTGA 
RP2034.7.2 GGTGACCTGAAGATCAGGCAGGAG 
RP2034.8.1 GGGGAAATACAGAGCCCCATCTGA 
RP2221.2.2 CCGCCCTTGAAGAGATTCTGTGTG 
RP2221.3.2 GCGGAGGGAGGGAGCTTTATCTTT 
RP2221.3.2 GCGGAGGGAGGGAGCTTTATCTTT 
RP2266.3.2 TCGCAGTCTGGGGGAATAAACTCA 
RP2266.4.1 TGTGTCCAAAAGTCCAGGTGTCCA 
RP2266.3.2 TCGCAGTCTGGGGGAATAAACTCA 
RP2266.4.1 TGTGTCCAAAAGTCCAGGTGTCCA 
RP2356.2.2 CCGATCAGAATGAGCAGTCCATGA 
RP2356.3.2 GCATCAAACATTCACGGATGTCCA 
RP2356.3.2 GCATCAAACATTCACGGATGTCCA 
RP2423.3.1 CCAAACATTCCAAGCCAAGATCCA 
RP2423.4.1 AGTTCCTGGCTCCGTGCCTTATGT 
RP2423.5.2 AAGTGTGTCGGCTAGGGGATCCTG 
RP2423.3.1 CCAAACATTCCAAGCCAAGATCCA 
RP2423.4.1 AGTTCCTGGCTCCGTGCCTTATGT 
RP2423.5.2 AAGTGTGTCGGCTAGGGGATCCTG 
RP2423.4.1 AGTTCCTGGCTCCGTGCCTTATGT 
RP2423.5.2 AAGTGTGTCGGCTAGGGGATCCTG 
RP2486.2.1 AGAGCTTACTCCACCTGCCGTCCT 
RP2519.2.2 TTCGGCCTCCGAAGTTCTCCCTAT 
RP2519.3.1 TGCTTGGTCAGTCAGCCTCCCTTA 
RP2519.3.1 TGCTTGGTCAGTCAGCCTCCCTTA 
RP2538.4.1 ATTGTTCCGAGCCATGCAGATGAG 
RP2538.5.4 CAGGCTCACGGACTGCATTGTTTT 
RP2538.6.4 TCCCACGCAGTGTGTCCTAGTGAA 
RP2538.4.1 ATTGTTCCGAGCCATGCAGATGAG 
RP2538.5.4 CAGGCTCACGGACTGCATTGTTTT 
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RP2538.6.4 TCCCACGCAGTGTGTCCTAGTGAA 
RP2538.4.1 ATTGTTCCGAGCCATGCAGATGAG 
RP2538.5.4 CAGGCTCACGGACTGCATTGTTTT 
RP2538.6.4 TCCCACGCAGTGTGTCCTAGTGAA 
RP2616.2.4 GGTTCCTTTGGCCGATGTCTTCAT 
RP2616.3.1 GTGCAGCGATAAATGAGGGACGAC 
RP2616.3.1 GTGCAGCGATAAATGAGGGACGAC 
RP2660.3.1 GAAGTTCATTGGCCCACACCTGAG 
RP2660.4.4 GCTCCATGAGTGCTCCATGATGTG 
RP2660.5.3 CACAAAGGGTGTCCAAGGTTCCAG 
RP2660.3.1 GAAGTTCATTGGCCCACACCTGAG 
RP2660.4.4 GCTCCATGAGTGCTCCATGATGTG 
RP2660.5.3 CACAAAGGGTGTCCAAGGTTCCAG 
RP2660.4.4 GCTCCATGAGTGCTCCATGATGTG 
RP2660.5.3 CACAAAGGGTGTCCAAGGTTCCAG 
RP2808.2.1 TCTTCCCCTCAATGTGCAAGTGGT 
RP2808.3.1 AGAAACCCTGGCAAGAGGACAAGG 
RP2808.3.1 AGAAACCCTGGCAAGAGGACAAGG 
RP2810.2.2 ATTGGGTTGGCTGTTCCACTGACA 
RP2810.3.4 TGCTTTGGGTGTGAGGTTGGACTT 
RP2810.3.4 TGCTTTGGGTGTGAGGTTGGACTT 
RP2847.2.5 GAAAGGCTCATGGGCATTGAACAC 
RP3471.3.1 CCAGAACGGACATTACCCAAAGCA 
RP3471.4.2 GCCAGAATACAGGTCAGCCTGTGC 
RP3471.5.3 ATGATGATGCAGTCTGGACGCAAA 
RP3471.3.1 CCAGAACGGACATTACCCAAAGCA 
RP3471.4.2 GCCAGAATACAGGTCAGCCTGTGC 
RP3471.5.3 ATGATGATGCAGTCTGGACGCAAA 
RP3471.4.2 GCCAGAATACAGGTCAGCCTGTGC 
RP3471.5.3 ATGATGATGCAGTCTGGACGCAAA 
RP3643.3.1 CAGGTCAGGTCAGAACGGAGGCTA 
RP3643.4.1 GTATGCCAGGCGCTATACGCAAGA 
RP3643.3.1 CAGGTCAGGTCAGAACGGAGGCTA 
RP3643.4.1 GTATGCCAGGCGCTATACGCAAGA 
RP4020.2.4 TCCGGCTGATGATGAACTGATTGA 
RP4185.2.2 CTTGTGGCTCGGGTCCATCTTACA 
RP4400.2.2 GGACAAGAAGTGGTCTCCGCAGTG 
RP4400.3.3 CGACATGGCTCTGGGCATATGTT 
RP4400.3.3 CGACATGGCTCTGGGCATATGTT 
RP4470.2.3 GAGCCACAGACTGAAGGGCTCAAA 
RP4470.3.1 CTTCCTTGGATGGAGATCGGGTGT 
RP4470.3.1 CTTCCTTGGATGGAGATCGGGTGT 
RP4845.2.1 CGGTAAAGCAGAAGTTGGCCTGTG 
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RP4845.3.2 AGCTCAAGCATGGCGGTTATGATG 
RP4845.3.2 AGCTCAAGCATGGCGGTTATGATG 
  
Primers used to amplify novel 3' exons on RefSeq genes 
RP1785.1.1 GAGGCACGTCCTAATCCACACTGG 
RP657.1.1 AGATGGAGGGTGTCCCGACTTCTC 
RP1576.1.4 GTGAGGCTCTTTTGGGGACATCAC 
RP2518.1.1 ACACATCGGACACCTTGTGCCTTT 
RP3522.1.1 AGAGCGGTAATGCAGCTGAACTCG 
RP4906.1.3 AGTGAGGCACGCAGAAATCCAGTT 
RP5032.1.1 GGGTCGAGGATTTTTAGGGATGGA 
RP688.1.3 ACATCCTAAGCGCTGGTTCCCCTA 
RP1778.1.1 ACAGAACCCCGTGGAGTACAAGCA 
RP1600.1.3 TGTTCTTCCGTAGGGCACCTCAGT 
forward forward_seq 
FPENSMUSG00000001281.15.1 GTGCGATCACAACCACTGTCAACC 
FPENSMUSG00000020839.13.1 ATGCCAGGGAGCCAATAAAGATGC 
FPENSMUSG00000022148.21.3 TCTGCTCTGTTCATTCCACTGTGC 
FPENSMUSG00000025035.6.4 CCGGGAGCTAGAGTCAGCCCTAGA 
FPENSMUSG00000028982.11.2 TACCTGCTGGGAGAGCGTGCTTAG 
FPENSMUSG00000032175.23.1 TTACTCTGCCTGGAAACCCCACCT 
FPENSMUSG00000032491.5.3 AGATCCGGCCACTTCATGTTCCTT 
FPENSMUSG00000033983.7.1 ATAGAGCATCTCGCCCATTCCACA 
FPENSMUSG00000037525.2.3 GGATGGAGTTAGCGTGCTGTTTCG 
FPENSMUSG00000038725.78.1 GTTCGTGTGGATTCACGACCCTTC 
  
Primers used to amplify novel 5' exons on Ref Seq genes 
FP3061.1.1 GCCTGACCCACAGACCAACTGACT 
FP1653.1.2 GCAGGTGAACAATCGTTGTGATCG 
FP2779.1.2 GGGGAATGGAAGCAGTCCTAGGTG 
FP864.1.1 CGGGGCTTACCTGAAGCTATGGAG 
FP4957.1.3 AGGTGACAGTGGAACCTGCAGACC 
FP4297.1.1 CCTTCAGCCCAAATGCTTGTCATC 
FP497.1.3 CCCCTGAATTCCAAGTGTGGTCTC 
FP1577.1.2 AGGACCAGGGAAACGAACCTACCC 
FP4957.1.3 AGGTGACAGTGGAACCTGCAGACC 
FP3572.1.1 GCAGTCTCCTTCCATCCATCGTTC 
RPENSMUSG00000053819.1.1 TTCCGAGCTCCTCAAAGAGCTGAT 
RPENSMUSG00000064210.1.2 GTCTCCATCCTCATCGTCGTCCTC 
RPENSMUSG00000039483.1.3 TTCCGCACCGGAAGTTATCCTACC 
RPENSMUSG00000032782.1.1 GAACGGTTAAAAGCGGATGTGCAA 
RPENSMUSG00000032733.1.1 AATCATAGAGGGCTCGGCCTTTCA 
RPENSMUSG00000030965.1.1 GAAGGTGTAGCCCGAAATGGAAGC 
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RPENSMUSG00000055053.1.1 GATGAACGGGTGGAACTCATCCTG 
RPENSMUSG00000054263.1.1 CAGGAGGGTCAGAGCTGACAGGAG 
RPENSMUSG00000032733.1.1 AATCATAGAGGGCTCGGCCTTTCA 
RPENSMUSG00000029195.1.5 TGCCAAGCAACAAGGTAAGGGTTG 
  
Primers used to amplify internal exons on RefSeq genes 
FP195.4.5 CCAACAGCCTAATGCTGAAGCACA 
FP234.3.1 GGCCCTGAACAGAAAACCTGGAAG 
FP355.4.1 AGTCCCTGGGCATTCCTCAGAAAA 
FP6974.3.1 TGTGTGGAGCACCATACCTACCACA 
FP4224.1.1 CCCGGAACCATGAACCCTAACTGT 
FP4533.1.1 TGCAAAAATACCAGTCCCCAGTGC 
FP4591.3.3 TCTCAGCCATTTTGCACAGACCAG 
FP10649.3.3 TCGTAGCCCTACTCTGTGCCCTTG 
FP14909.2.3 CCTTGAGACCACGTCTCTGCTTCC 
FP15423.2.2 TCCAGGAAACAGATCCTCGACTGG 
FP15030.2.1 AATGTTCACTCACACCGGGCAGTT 
FP18233.4.1 CTTCGGTCCCTTTAGCCGTTCTTG 
FP19324.1.4 TTCGGAGGTCTGGACAGACTAGCA 
FP20705.2.1 TGGCAGCAAAAATTCCCTTCTGA 
FP23834.3.1 TAGGCACCATCTTGTAGCCCTGGA 
FP29245.3.2 GGTTCATCCCAAAACTGATGAGCA 
FP29854.3.2 AGAAGCCTCCTTCACTCCCCAGGT 
FP9538.2.3 GCTGCGACTTGCAGTCGATGGTAT 
FP31215.3.1 CTGTGAAGTTCCATGCCAGGACAG 
FP23698.1.1 ATGGGAAAAAGCAGTGGGATTTGG 
RP195.5.2 TTAGCATCAGCGACAGCCAGAGGT 
RP234.4.1 TCTGCTTCCCGTCTTCATAGTGGA 
RP355.5.3 CCACTCTTCCTTCATGGGTGCAAG 
RP6974.4.1 TTGGAGATCATGGAAGTGGCTCGT 
RP4224.2.2 AACTTTGCCCACACCCAGGTCTCT 
RP4533.2.1 CTTGGCTCTAACACAGCAGCAGCA 
RP4591.4.1 CTATGGGCCTCGATGCATGATCTC 
RP10649.4.1 ACCTGATTCGCTGGCGTAGAGATG 
RP14909.3.1 ACCTGGGGAGGAACACACTTTCCA 
RP15423.3.2 GATACCATGCAGTGCAAAGCACCT 
RP15030.3.2 TAAGCTGTGTGCAGTCTGAAGCAA 
RP18233.5.1 GAGTGTACCCTGCCGGCTTCTTCT 
RP19324.2.4 TTAGAAGGGCTTTGGGGGATGGTT 
RP20705.3.1 CCTAGGAAGCGAGGGGTCTGGTTC 
RP23834.4.1 TCGATCTTGCTGGACCACTTCTCC 
RP29245.4.2 GCATGTTTCCTCTTCCGTTCGAAAA 
RP29854.4.3 TCTGTCTGTCAGCCATCAACAGCA 
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RP9538.3.1 CGCTGAGAGACACCATCACAAAGC 
RP31215.4.5 GTATGCTGTTCTCCTGGGCCATGT 
RP23698.2.1 AGGCACAGCTGTAGGTTGGTTTCG 
  
Primers on hypertrapped genes  
FPE577769 GCCATACACCATGGATGCGTTC 
FPE141136 GCACACCTTACGGACACGGAGA 
FPE214933  GGCCATCCATAACCGAGGGAAA 
FPE110463 ACTAGCGCCACCGCCCTTTCT 
FPE277766  TTGGACAGGCGCATGGTTAAGG 
FPE352331  CGGCAAAGCCGAGAAGGAGAAC 
FPE250850  CCCTACAGTGGCTGTGGGAAAGTC 
FPE106542  GCTTCCGACATGATGGTTCTCCTG 
FPE295390   GATGACCCGCAGAGTGGAGAGC 
FPE214915  TGGAATCCGCGAAGATCAGAGC 
RPE577768 AGCAAATCCGGGGTAGCCTCTG 
RPE511104 GCTGGTTGTGAATTACTTCCTTGG 
RPE392401 CTGCCTGTGGTCCACTCGATCC 
RPE396136 GAAGATGGCCTGCCACTCAGGA 
RPE127477  CCAAGTTCTTCTCAGGTTCCCAAG 
RPE582536 GGGCTTGATGTCCAGAGGCAGA 
RPE362649 CTGGCCACGTGCAGGGAAAG 
RPE264351 CCAGCAGCCATCTTTCCTCCGTA 
RPE295384 GGTGTTGGGCTCATTAAGCAGTGA 
RPE214916 TGTCAACAATCTGAGAGCCCGAGA 
  
Primers on trapped RefSeq  
NP_808265.1 CACCAGCACCATCAGCCCATTT 
Cklfsf5 ACCAGCGCTTCGATAGGCTCAA 
Gcnt3 CTCCACATCACTCACGGCGTTG 
Cbr1 AATACGGAGGCCTGGACGTGCT 
Ly6g6c TCCTGTTGCTCACCCTGTCTGC 
Zik1 TGCAGAAATGGATATGGCCCTCA 
Gprc5b CCAGTGCACCGTTCAGAAGCAA 
Egr1 GGAGCCGAGCGAACAACCCTAT 
Tceal1 CCTTGATCGAGAAGGAAAGCAGAA 
2610319K07Rik CGCCGTACTTGCAGGAAAGCAG 
RPE365971 AGACCCATCACATCGGCAAGGA 
RPE320895 GCAGCAAAGGAGACCACCAGGA 
RPE217909 CATCAAGCCTTGCCCAGCAGAG 
RPE253497 TTGAATGTGGAAGGGGGTGTCG 
RPE141753 ACAGCCCAGCACAGGGACTTTG 
RPE198304 TCTCCATTCTTCATGGGAGAAGCAA 
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RPE410397 GTGTGAGATGGCGGAGCAGTTG 
RPE433523 TCGTCTCCACCATCGCCTTCTC 
RPE389668 CTCTTCATTTTCACTGCGCGTGTT 
RPE177331 CGGGAATACCACTTGTTCCTGGAC 
  
  
Primers used to amplify fragments tested in zebrafish 
2894F  CAAATGACAGACGCACCTAAG 
2894R  TTCTCTTTGTGGTCCCTGCT 
2755F  GGTATCTGTGCGCCTTTTCT 
2755R  CAGATTTGAATTTGCAGCGA 
2756F  CGCAGATGAAATTGGACAGA 
2756R  GACAGGACATCAGGACAGGC 
1645F  GGGATGTGTTCTCCATGCTT 
1645R  CAATACAATGACGGAGAGGG 
1646F  CCGATTCTCCCATCAGTTCA 
1646R  CTGTAGTGGGGCAACAGGAG 
1652F  ACATTCAGAAGAGCCAGCGT 
1652R  GCAGCCATAGTTCCCAGTCT 
1653F  AGCCTAAACACACCACCTCG 
1653R  CGTGAGAAAATGGCTGACGTA 
1653IF  GTCCCGGTACACAACAAGGA 
1553IR  GACATTCTGGAACCCTCCAA 
333F  AACCACGAGTGAAACTCGGA 
333R  CATTCAGCCTGGCTCTCTGT 
1194F  TGACACAACGGGAAACTACA 
1194R  GAACTGGGAAGTGTGCAAGG 
2598F  ATACCCCTGGGTTAAAAGGC 
2598R  GCTGCTGAACAGCGGTAAGT 
2598IF  TGCACCTCTGATTGAGGAGTT 
2598IR  CCCCTGTCTTTATGAGATAACCA 
44F  CACGTGTTGTGCTTGTTTCC 
44R  TCCTTTACCTTCCAACCCTG 
45F  CCCTAGGAGGGGTCTCAGTAG 
45R  ATGCTTCCATCTGCTGGTCT 
691F  GCATACAGTCGCCCAAACTC 
691R  ACGCTTAGGTATCAGCGGAG 
692F  GCTTGTTGACGGAGTGGTTC 
692R  CAGAACGCTGCTTTGTGAGA 
1050F  TAGCCTGATGGCCATTAACA 
1050R  GGAAACTTACATTCGCTCCC 
1051F  AGATAGCACAGGCCAGATGAA 
1051R  GGAGCGATAAAAAGATGAGCA 
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1052F  TGGGGAGAAACAATGTAGGC 
1052R  GAAACCCTCCTCCATGATCC 
3120F  AAGACTCTTTTGGTGGCCTCT 
3120R  TCAAGAGGGTGATGGTCTCTG 
3121F  ATCCAATTTGGCTGATCCTG 
3121R  TGTTGTCTGACGCTCAATGC 
3122F  GTGCGCTCATTACCAGCTCT 
3122R  GGAGTACAAGTGCAACTGCC 
1972F  TTAGGCACTGGGGACAGAGT 
1972R  TTGATGGTGGTTGCATTTTG 
1973F  GTGAGGCAGGCTTGGTTAAG 
1973R  AAGTCTCCTGGAGCCATCTTC 
4939F  GGTGGTTTTCCCTGACTGAG 
4939R  TGGCAGTCTAGAGCCACCAT 
4940F  GGGCAATATCAGAGCGAGAC 
4940R  CCCTCAAATGTTCCTGTTCG 
2032F  TGGCTTTTGTCCATTCTGTG 
2032R  ATCCCTAACCCAACATTCTGT 
4049F  GTCACCCGCTGTTATGATTG 
4049R  GTTCTGCCCACGACTGATCT 
  
Primer used to amplify negative controls fragments 
VC11216F TCTGCTTACAGATGCTGGCT 
VC3255F CCCATAATGGACACCCTCTG 
VC2797F  GGTGGTCGGCTGTAAAAAGA 
VC198F  TGCTTAGTTTGTGTCGGTGG 
VC909F  GTGTGTCATCCTCATCCACG 
VC410F  GGAAGCCTTTTTACCCCAGA 
VC10157F  TTGGAGATCAGATCACAGGG 
VC11271F  GCCGTTGCGTTTTATTTAGC 
VC5990F  CAGTGTTGCAGGCAGAAGAA 
VC268F  TCTTCTTTCCGTCGAACTGG 
VC11767F  CCTTTCATACGTCGCTCGAT 
VC5945F  GTCCGCGAGTGCAATAAATC 
VC11216R CTCGTAAAGGGTGTGGTGTG 
VC3255R GTTCTGGACGCATCAGGATT 
VC2797R CGGTGGTCCCTATCTGAGTC 
VC198R TCCTCCATTTTGTTTGGTCC 
VC909R CATTCCATGATGGTGCTCTG 
VC410R TCATATCCAAACCCGAGGAG 
VC10157R CGATGGATGAATCAGCAAGA 
VC11271R CAGCTGCTAAGGATCATGGG 
VC5990R CAAGGGAACACGGGGTATTA 
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VC268R TCCGGATGATGGTGTTACAG 
VC11767R CGTGTTGCCTAAACACAACC 
VC5945R TGCAGAGGTCACAGAAATGC 
  
Primer used to amplify positive controls fragments 
VF17653F CTGTCGGTCAGACTCCAACA 
VF17654F  AGTTCACCTGGTGTGCTGAA 
VF17655F  CATCAGTGACACATGGCGTT 
VF17656F GGCCCCATAAAGGTTCATTC 
VF5490F  GTGTGGTGACTCAGCCATGT 
VF5491F  GCCATTGATTCCCTCCAGAC 
VF5492F  GTTTAGCTCCAGCCCTGATG 
FF6026F  CCAATATTTCCCATCAGCCT 
FF12058F  GTGTCGACTCGAGGTGAAGA 
FF12057F ACACGCTTCCTGGAGATGAC 
FF28050F GACGTCACCGTGGAATTGTC 
VF17653R CAGCAATGGAAGCAGTGAGA 
VF17654R AGCCATTTCTTTCGTTACGG 
VF17655R GGAAGGAAACTGTGGGAATG 
VF17656R CCCTCCATAAAACAGCTCACA 
VF5490R GGACAACTGGGATTGTGGTT 
VF5491R GGAAGGGAATTTTGGCACTT 
VF5492R GAGCACTAACCTCGACAGGC 
FF6026R GCACGCGTCACAATGTCTTA 
FF12058R GCTTGAATCGAGGTCTCAGC 
FF12057R CTGAAGACAGACTCCGTCCC 
FF28050R AATTAGGCCGAAGGGGTAAG 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
